CA2420178A1 - Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists - Google Patents
Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists Download PDFInfo
- Publication number
- CA2420178A1 CA2420178A1 CA002420178A CA2420178A CA2420178A1 CA 2420178 A1 CA2420178 A1 CA 2420178A1 CA 002420178 A CA002420178 A CA 002420178A CA 2420178 A CA2420178 A CA 2420178A CA 2420178 A1 CA2420178 A1 CA 2420178A1
- Authority
- CA
- Canada
- Prior art keywords
- methyl
- alkyl
- compound
- phenoxy
- ethoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000556 agonist Substances 0.000 title description 7
- 229940083759 high-ceiling diuretics aryloxyacetic acid derivative Drugs 0.000 title description 2
- 101150014691 PPARA gene Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 224
- -1 R2 is H Chemical group 0.000 claims abstract description 77
- 150000003839 salts Chemical class 0.000 claims abstract description 60
- 239000012453 solvate Substances 0.000 claims abstract description 32
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 claims abstract description 30
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 claims abstract description 30
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 27
- 238000011282 treatment Methods 0.000 claims abstract description 21
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 20
- 150000004677 hydrates Chemical class 0.000 claims abstract description 16
- 206010012601 diabetes mellitus Diseases 0.000 claims abstract description 14
- 125000001188 haloalkyl group Chemical group 0.000 claims abstract description 12
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 6
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims abstract description 5
- 125000004957 naphthylene group Chemical group 0.000 claims abstract description 4
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 4
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims abstract description 3
- 125000003107 substituted aryl group Chemical group 0.000 claims abstract 3
- 238000000034 method Methods 0.000 claims description 107
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 52
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 37
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 31
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 30
- 241000124008 Mammalia Species 0.000 claims description 30
- 239000008103 glucose Substances 0.000 claims description 30
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 28
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 28
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 25
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims description 21
- 125000003118 aryl group Chemical group 0.000 claims description 18
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 16
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 16
- 102000005962 receptors Human genes 0.000 claims description 16
- 108020003175 receptors Proteins 0.000 claims description 16
- 210000004369 blood Anatomy 0.000 claims description 15
- 239000008280 blood Substances 0.000 claims description 15
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 14
- 210000002966 serum Anatomy 0.000 claims description 14
- 150000003626 triacylglycerols Chemical class 0.000 claims description 14
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 13
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims description 13
- 235000019260 propionic acid Nutrition 0.000 claims description 12
- 239000008194 pharmaceutical composition Substances 0.000 claims description 11
- 208000011580 syndromic disease Diseases 0.000 claims description 9
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 8
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 8
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 8
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 7
- 108010007622 LDL Lipoproteins Proteins 0.000 claims description 7
- 102000007330 LDL Lipoproteins Human genes 0.000 claims description 7
- 125000001624 naphthyl group Chemical group 0.000 claims description 7
- 108010010234 HDL Lipoproteins Proteins 0.000 claims description 6
- 102000015779 HDL Lipoproteins Human genes 0.000 claims description 6
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 6
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims description 5
- 239000003937 drug carrier Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 4
- 125000004104 aryloxy group Chemical group 0.000 claims description 4
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 125000004470 heterocyclooxy group Chemical group 0.000 claims description 4
- VUWCWQJMPHAOGO-UHFFFAOYSA-N 2-[4-[[5-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-4-yl]methylsulfanyl]-2-propylphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(CCC)=CC(SCC2=C(OC(=N2)C=2C=CC(=CC=2)C(F)(F)F)C)=C1 VUWCWQJMPHAOGO-UHFFFAOYSA-N 0.000 claims description 3
- NFSZHNDIBOJZMH-UHFFFAOYSA-N 2-[2-(benzylcarbamoyloxymethyl)-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1COC(=O)NCC1=CC=CC=C1 NFSZHNDIBOJZMH-UHFFFAOYSA-N 0.000 claims description 2
- XIAOXDSZPFFSDG-UHFFFAOYSA-N 2-[2-[(2-fluorophenoxy)methyl]-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1COC1=CC=CC=C1F XIAOXDSZPFFSDG-UHFFFAOYSA-N 0.000 claims description 2
- FLTAJWFZFOEKPE-UHFFFAOYSA-N 2-[2-[(3-fluorophenoxy)methyl]-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1COC1=CC=CC(F)=C1 FLTAJWFZFOEKPE-UHFFFAOYSA-N 0.000 claims description 2
- NTVGDUHBPXQEFC-UHFFFAOYSA-N 2-[2-[(4-fluorophenyl)methylcarbamoyloxymethyl]-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1COC(=O)NCC1=CC=C(F)C=C1 NTVGDUHBPXQEFC-UHFFFAOYSA-N 0.000 claims description 2
- AZFFNZFFAWPVGO-UHFFFAOYSA-N 2-[2-methyl-4-[[5-methyl-2-(4-phenylmethoxyphenyl)-1,3-oxazol-4-yl]methoxy]phenoxy]acetic acid Chemical compound CC=1OC(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)=NC=1COC1=CC=C(OCC(O)=O)C(C)=C1 AZFFNZFFAWPVGO-UHFFFAOYSA-N 0.000 claims description 2
- FDXZNRILKJRXFZ-UHFFFAOYSA-N 2-[4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methylsulfanyl]-2-propylphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(CCC)=CC(SCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 FDXZNRILKJRXFZ-UHFFFAOYSA-N 0.000 claims description 2
- DKFOBENNWPSTSZ-UHFFFAOYSA-N 2-[4-[2-[2-(4-butoxyphenyl)-5-methyl-1,3-oxazol-4-yl]ethylsulfanyl]-2-methylphenoxy]acetic acid Chemical compound C1=CC(OCCCC)=CC=C1C1=NC(CCSC=2C=C(C)C(OCC(O)=O)=CC=2)=C(C)O1 DKFOBENNWPSTSZ-UHFFFAOYSA-N 0.000 claims description 2
- ICGGAQRMHQTVIJ-UHFFFAOYSA-N 2-[4-[[2-(4-bromophenyl)-5-methyl-1,3-oxazol-4-yl]methylsulfanyl]-2-propylphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(CCC)=CC(SCC2=C(OC(=N2)C=2C=CC(Br)=CC=2)C)=C1 ICGGAQRMHQTVIJ-UHFFFAOYSA-N 0.000 claims description 2
- ARVAGKAGELVHQW-UHFFFAOYSA-N 2-[4-[[5-methyl-2-(4-phenylmethoxyphenyl)-1,3-oxazol-4-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound CC=1OC(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)=NC=1CSC1=CC=C(OCC(O)=O)C=C1 ARVAGKAGELVHQW-UHFFFAOYSA-N 0.000 claims description 2
- OATAPOLIZUPPKP-UHFFFAOYSA-N 2-methyl-2-[2-[(2-methylphenoxy)methyl]-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1COC1=CC=CC=C1C OATAPOLIZUPPKP-UHFFFAOYSA-N 0.000 claims description 2
- PJGRWERWZGEXKL-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-(phenylmethoxymethyl)phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1COCC1=CC=CC=C1 PJGRWERWZGEXKL-UHFFFAOYSA-N 0.000 claims description 2
- GISUZFBXHMYFBU-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-[(2-phenylphenoxy)methyl]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1COC1=CC=CC=C1C1=CC=CC=C1 GISUZFBXHMYFBU-UHFFFAOYSA-N 0.000 claims description 2
- UHUFIBDLDIPUIS-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-[(4-phenylphenoxy)methyl]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1COC(C=C1)=CC=C1C1=CC=CC=C1 UHUFIBDLDIPUIS-UHFFFAOYSA-N 0.000 claims description 2
- FDUADOLBLVYJOH-UHFFFAOYSA-N 4-[4-[[4-(carboxymethoxy)-3-methylphenoxy]methyl]-5-methyl-1,3-oxazol-2-yl]benzoic acid Chemical compound CC=1OC(C=2C=CC(=CC=2)C(O)=O)=NC=1COC1=CC=C(OCC(O)=O)C(C)=C1 FDUADOLBLVYJOH-UHFFFAOYSA-N 0.000 claims description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 2
- 125000001475 halogen functional group Chemical group 0.000 claims 11
- 125000004171 alkoxy aryl group Chemical group 0.000 claims 2
- AMTSXQFDEKDAFV-UHFFFAOYSA-N 2-[2-[(4-fluorophenoxy)methyl]-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1COC1=CC=C(F)C=C1 AMTSXQFDEKDAFV-UHFFFAOYSA-N 0.000 claims 1
- MXSBPMNCHHMWGK-UHFFFAOYSA-N 2-[4-[[5-methyl-2-(4-phenylmethoxyphenyl)-1,3-oxazol-4-yl]methoxy]phenoxy]acetic acid Chemical compound CC=1OC(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)=NC=1COC1=CC=C(OCC(O)=O)C=C1 MXSBPMNCHHMWGK-UHFFFAOYSA-N 0.000 claims 1
- UOWSULYBSTUTCV-UHFFFAOYSA-N 2-[4-[[5-methyl-2-(4-phenylmethoxyphenyl)-1,3-oxazol-4-yl]methylsulfanyl]-2-propylphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(CCC)=CC(SCC2=C(OC(=N2)C=2C=CC(OCC=3C=CC=CC=3)=CC=2)C)=C1 UOWSULYBSTUTCV-UHFFFAOYSA-N 0.000 claims 1
- OAKHWYJZGOULJN-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-(propan-2-ylcarbamoyloxymethyl)phenoxy]propanoic acid Chemical compound C1=C(OC(C)(C)C(O)=O)C(COC(=O)NC(C)C)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 OAKHWYJZGOULJN-UHFFFAOYSA-N 0.000 claims 1
- 241001367053 Autographa gamma Species 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 abstract 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 294
- 238000005160 1H NMR spectroscopy Methods 0.000 description 220
- 101150041968 CDC13 gene Proteins 0.000 description 218
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 218
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 216
- 235000019439 ethyl acetate Nutrition 0.000 description 134
- 239000000203 mixture Substances 0.000 description 132
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 119
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 118
- 239000000243 solution Substances 0.000 description 96
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 88
- 238000006243 chemical reaction Methods 0.000 description 80
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 80
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 72
- 239000007787 solid Substances 0.000 description 65
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 63
- 239000012044 organic layer Substances 0.000 description 62
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 52
- 239000012267 brine Substances 0.000 description 51
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 51
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 50
- 239000003921 oil Substances 0.000 description 47
- 235000019198 oils Nutrition 0.000 description 47
- 235000002639 sodium chloride Nutrition 0.000 description 46
- 239000000047 product Substances 0.000 description 45
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 44
- 239000011734 sodium Substances 0.000 description 39
- 239000002904 solvent Substances 0.000 description 39
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 38
- 239000011541 reaction mixture Substances 0.000 description 37
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 36
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
- 229910000024 caesium carbonate Inorganic materials 0.000 description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 32
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 32
- 239000012043 crude product Substances 0.000 description 31
- 238000000524 positive electrospray ionisation mass spectrometry Methods 0.000 description 31
- 239000004480 active ingredient Substances 0.000 description 30
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 29
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 29
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 28
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 28
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 28
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 26
- 102000004877 Insulin Human genes 0.000 description 26
- 108090001061 Insulin Proteins 0.000 description 26
- 239000012230 colorless oil Substances 0.000 description 26
- 229940125396 insulin Drugs 0.000 description 26
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 25
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 25
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 23
- 150000002148 esters Chemical class 0.000 description 23
- 239000002253 acid Substances 0.000 description 22
- 238000004587 chromatography analysis Methods 0.000 description 21
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 20
- 239000001257 hydrogen Substances 0.000 description 20
- 229910052739 hydrogen Inorganic materials 0.000 description 20
- 239000003826 tablet Substances 0.000 description 20
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 18
- 238000003818 flash chromatography Methods 0.000 description 18
- 238000009472 formulation Methods 0.000 description 18
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 17
- 238000010992 reflux Methods 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 15
- 239000002585 base Substances 0.000 description 15
- 239000002775 capsule Substances 0.000 description 15
- 239000010410 layer Substances 0.000 description 15
- QGNITQXBLBMGSS-UHFFFAOYSA-N 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl 4-methylbenzenesulfonate Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOS(=O)(=O)C1=CC=C(C)C=C1 QGNITQXBLBMGSS-UHFFFAOYSA-N 0.000 description 14
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 14
- 229910052757 nitrogen Inorganic materials 0.000 description 14
- 239000000706 filtrate Substances 0.000 description 13
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 13
- 239000000843 powder Substances 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- 229920002472 Starch Polymers 0.000 description 12
- 125000004494 ethyl ester group Chemical group 0.000 description 12
- 239000000651 prodrug Substances 0.000 description 12
- 229940002612 prodrug Drugs 0.000 description 12
- 239000000741 silica gel Substances 0.000 description 12
- 229910002027 silica gel Inorganic materials 0.000 description 12
- 235000019698 starch Nutrition 0.000 description 12
- 235000012000 cholesterol Nutrition 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 239000012074 organic phase Substances 0.000 description 11
- 230000002829 reductive effect Effects 0.000 description 11
- 239000008107 starch Substances 0.000 description 11
- 239000000725 suspension Substances 0.000 description 11
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 10
- 239000010779 crude oil Substances 0.000 description 10
- IOLQWGVDEFWYNP-UHFFFAOYSA-N ethyl 2-bromo-2-methylpropanoate Chemical compound CCOC(=O)C(C)(C)Br IOLQWGVDEFWYNP-UHFFFAOYSA-N 0.000 description 10
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 10
- 239000000543 intermediate Substances 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 9
- 238000004440 column chromatography Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 229910000027 potassium carbonate Inorganic materials 0.000 description 9
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- 239000013543 active substance Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 230000027455 binding Effects 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 8
- 241000208125 Nicotiana Species 0.000 description 7
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- GYPAUSRXYPLNAP-UHFFFAOYSA-N ethyl 2-(4-hydroxyphenoxy)-2-methylpropanoate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(O)C=C1 GYPAUSRXYPLNAP-UHFFFAOYSA-N 0.000 description 7
- 235000019359 magnesium stearate Nutrition 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 125000001424 substituent group Chemical group 0.000 description 7
- 239000003981 vehicle Substances 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
- 208000008589 Obesity Diseases 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000000010 aprotic solvent Substances 0.000 description 6
- 239000012298 atmosphere Substances 0.000 description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 6
- SMVLDNUJSZVHQF-UHFFFAOYSA-N ethyl 2-[4-[2-[2-(4-bromophenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC(Br)=CC=2)=N1 SMVLDNUJSZVHQF-UHFFFAOYSA-N 0.000 description 6
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 6
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 6
- 235000020824 obesity Nutrition 0.000 description 6
- 235000011181 potassium carbonates Nutrition 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- 239000006188 syrup Substances 0.000 description 6
- 235000020357 syrup Nutrition 0.000 description 6
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 5
- 201000001320 Atherosclerosis Diseases 0.000 description 5
- 206010022489 Insulin Resistance Diseases 0.000 description 5
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 5
- 229940100389 Sulfonylurea Drugs 0.000 description 5
- 229940123464 Thiazolidinedione Drugs 0.000 description 5
- 229910000085 borane Inorganic materials 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 125000005843 halogen group Chemical group 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 239000000454 talc Substances 0.000 description 5
- 229910052623 talc Inorganic materials 0.000 description 5
- 235000012222 talc Nutrition 0.000 description 5
- 150000001467 thiazolidinediones Chemical class 0.000 description 5
- JYWHQBLLIBQGCU-UHFFFAOYSA-N 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethanol Chemical compound OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 JYWHQBLLIBQGCU-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 210000000577 adipose tissue Anatomy 0.000 description 4
- 239000000443 aerosol Substances 0.000 description 4
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 4
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 239000008298 dragée Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- ULFHBHMAHKMHSV-UHFFFAOYSA-N ethyl 2-[4-[2-[2-(4-hydroxyphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC(O)=CC=2)=N1 ULFHBHMAHKMHSV-UHFFFAOYSA-N 0.000 description 4
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 description 4
- 229960002297 fenofibrate Drugs 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 201000001421 hyperglycemia Diseases 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000012280 lithium aluminium hydride Substances 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- 238000010606 normalization Methods 0.000 description 4
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- SBNVFWXTMCXMBN-UHFFFAOYSA-N 2-[2-(4-bromophenyl)-5-methyl-1,3-oxazol-4-yl]ethanol Chemical compound OCCC1=C(C)OC(C=2C=CC(Br)=CC=2)=N1 SBNVFWXTMCXMBN-UHFFFAOYSA-N 0.000 description 3
- PIPMIWBXCPFVRR-UHFFFAOYSA-N 2-[2-(4-bromophenyl)-5-methyl-1,3-oxazol-4-yl]ethyl 4-methylbenzenesulfonate Chemical compound CC=1OC(C=2C=CC(Br)=CC=2)=NC=1CCOS(=O)(=O)C1=CC=C(C)C=C1 PIPMIWBXCPFVRR-UHFFFAOYSA-N 0.000 description 3
- OITJQVZEPIVZRK-UHFFFAOYSA-N 2-[2-butyl-5-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound C1=C(OC(C)(C)C(O)=O)C(CCCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 OITJQVZEPIVZRK-UHFFFAOYSA-N 0.000 description 3
- BWBIHHDMRZNEFB-UHFFFAOYSA-N 2-[4-[2-[2-(4-cyclohexyloxyphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C=2C=CC(OC3CCCCC3)=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 BWBIHHDMRZNEFB-UHFFFAOYSA-N 0.000 description 3
- QWOYXKJVOWTEOV-UHFFFAOYSA-N 2-[4-[2-[2-(4-hydroxyphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C=2C=CC(O)=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 QWOYXKJVOWTEOV-UHFFFAOYSA-N 0.000 description 3
- MXTLOKMQLWGGRC-UHFFFAOYSA-N 2-[4-[2-[2-[4-(4-benzoylphenoxy)phenyl]-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C=2C=CC(OC=3C=CC(=CC=3)C(=O)C=3C=CC=CC=3)=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 MXTLOKMQLWGGRC-UHFFFAOYSA-N 0.000 description 3
- DKMLQSWVPIFXOC-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3,5-dipropylphenoxy]propanoic acid Chemical compound CCCC1=CC(OC(C)(C)C(O)=O)=CC(CCC)=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 DKMLQSWVPIFXOC-UHFFFAOYSA-N 0.000 description 3
- KUEQBGZFDSFUAK-UHFFFAOYSA-N 2-methyl-2-[4-[2-[5-methyl-2-(4-phenoxyphenyl)-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC(OC=3C=CC=CC=3)=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 KUEQBGZFDSFUAK-UHFFFAOYSA-N 0.000 description 3
- OMIACGDSWRLDNS-UHFFFAOYSA-N 4-phenylmethoxy-2,6-bis(prop-2-enyl)phenol Chemical compound C1=C(CC=C)C(O)=C(CC=C)C=C1OCC1=CC=CC=C1 OMIACGDSWRLDNS-UHFFFAOYSA-N 0.000 description 3
- MHKMPNFGLYREOZ-UHFFFAOYSA-N 4-phenylmethoxy-2-propylphenol Chemical compound C1=C(O)C(CCC)=CC(OCC=2C=CC=CC=2)=C1 MHKMPNFGLYREOZ-UHFFFAOYSA-N 0.000 description 3
- GVTDRUXHMYZTFF-UHFFFAOYSA-N 5,6,7,8-tetrahydronaphthalene-1,4-diol Chemical compound C1CCCC2=C1C(O)=CC=C2O GVTDRUXHMYZTFF-UHFFFAOYSA-N 0.000 description 3
- 102000004539 Acyl-CoA Oxidase Human genes 0.000 description 3
- 108020001558 Acyl-CoA oxidase Proteins 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- VOPWNXZWBYDODV-UHFFFAOYSA-N Chlorodifluoromethane Chemical compound FC(F)Cl VOPWNXZWBYDODV-UHFFFAOYSA-N 0.000 description 3
- 102100024099 Disks large homolog 1 Human genes 0.000 description 3
- 102100039556 Galectin-4 Human genes 0.000 description 3
- 101001053984 Homo sapiens Disks large homolog 1 Proteins 0.000 description 3
- 101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 238000005903 acid hydrolysis reaction Methods 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 229940105329 carboxymethylcellulose Drugs 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000002648 combination therapy Methods 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- CNXMDTWQWLGCPE-UHFFFAOYSA-N ditert-butyl-(2-phenylphenyl)phosphane Chemical group CC(C)(C)P(C(C)(C)C)C1=CC=CC=C1C1=CC=CC=C1 CNXMDTWQWLGCPE-UHFFFAOYSA-N 0.000 description 3
- JWDBRRAPCBJDNU-UHFFFAOYSA-N ethyl 2-(4-hydroxynaphthalen-1-yl)oxy-2-methylpropanoate Chemical compound C1=CC=C2C(OC(C)(C)C(=O)OCC)=CC=C(O)C2=C1 JWDBRRAPCBJDNU-UHFFFAOYSA-N 0.000 description 3
- JQEAYBFCCPUIPQ-UHFFFAOYSA-N ethyl 2-[(4-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)oxy]-2-methylpropanoate Chemical compound C1CCCC2=C1C(O)=CC=C2OC(C)(C)C(=O)OCC JQEAYBFCCPUIPQ-UHFFFAOYSA-N 0.000 description 3
- IFOFSEVMOAAGAP-UHFFFAOYSA-N ethyl 2-[2-(hydroxymethyl)-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=C(CO)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 IFOFSEVMOAAGAP-UHFFFAOYSA-N 0.000 description 3
- DLEDBIQYBFADHT-UHFFFAOYSA-N ethyl 2-[4-[2-[2-(3-bromophenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=C(Br)C=CC=2)=N1 DLEDBIQYBFADHT-UHFFFAOYSA-N 0.000 description 3
- FBTMJUPZIYAQCJ-UHFFFAOYSA-N ethyl 2-[4-[2-[2-(4-cyanophenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC(=CC=2)C#N)=N1 FBTMJUPZIYAQCJ-UHFFFAOYSA-N 0.000 description 3
- DMFVDXUWZJBLJP-UHFFFAOYSA-N ethyl 2-[4-[2-[2-(4-cyclohexyloxyphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC(OC3CCCCC3)=CC=2)=N1 DMFVDXUWZJBLJP-UHFFFAOYSA-N 0.000 description 3
- MVMUYEOGBFWVIF-UHFFFAOYSA-N ethyl 2-[4-[2-[2-(4-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC(OC)=CC=2)=N1 MVMUYEOGBFWVIF-UHFFFAOYSA-N 0.000 description 3
- VQLKFJQONHFYOU-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]naphthalen-1-yl]oxypropanoate Chemical compound C12=CC=CC=C2C(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C1=CC=CC=C1 VQLKFJQONHFYOU-UHFFFAOYSA-N 0.000 description 3
- VQUSEQASNPSITG-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 VQUSEQASNPSITG-UHFFFAOYSA-N 0.000 description 3
- RABHSTUFZOIQOU-UHFFFAOYSA-N ethyl 2-methyl-2-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]propanoate Chemical compound C1=2CCCCC=2C(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C1=CC=CC=C1 RABHSTUFZOIQOU-UHFFFAOYSA-N 0.000 description 3
- 229940125753 fibrate Drugs 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 238000004811 liquid chromatography Methods 0.000 description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 3
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 238000004007 reversed phase HPLC Methods 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000000375 suspending agent Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 3
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 239000003039 volatile agent Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- REOCVFHCRZMTTR-UHFFFAOYSA-N 2-(2-prop-2-enylphenoxy)acetic acid Chemical compound OC(=O)COC1=CC=CC=C1CC=C REOCVFHCRZMTTR-UHFFFAOYSA-N 0.000 description 2
- SGHQKGYEIKXIFL-UHFFFAOYSA-N 2-(4-bromophenyl)-4,5-dimethyl-3-oxido-1,3-oxazol-3-ium Chemical compound CC1=C(C)OC(C=2C=CC(Br)=CC=2)=[N+]1[O-] SGHQKGYEIKXIFL-UHFFFAOYSA-N 0.000 description 2
- WUMQZKBNFDQXFK-UHFFFAOYSA-N 2-(4-bromophenyl)-4-(chloromethyl)-5-methyl-1,3-oxazole Chemical compound ClCC1=C(C)OC(C=2C=CC(Br)=CC=2)=N1 WUMQZKBNFDQXFK-UHFFFAOYSA-N 0.000 description 2
- LFWWGOVVMHFOKV-UHFFFAOYSA-N 2-(5-methyl-2-phenyl-1,3-thiazol-4-yl)ethanol Chemical compound OCCC1=C(C)SC(C=2C=CC=CC=2)=N1 LFWWGOVVMHFOKV-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical class CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- FCVXIPPJDZQRCK-UHFFFAOYSA-N 2-[2-(4-bromophenyl)-5-methyl-1,3-oxazol-4-yl]acetic acid Chemical compound OC(=O)CC1=C(C)OC(C=2C=CC(Br)=CC=2)=N1 FCVXIPPJDZQRCK-UHFFFAOYSA-N 0.000 description 2
- YQKQCAFUXMWRJI-UHFFFAOYSA-N 2-[2-(4-bromophenyl)-5-methyl-1,3-oxazol-4-yl]acetonitrile Chemical compound N#CCC1=C(C)OC(C=2C=CC(Br)=CC=2)=N1 YQKQCAFUXMWRJI-UHFFFAOYSA-N 0.000 description 2
- RGLKVHTZNHANJT-UHFFFAOYSA-N 2-[2-ethyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(CC)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 RGLKVHTZNHANJT-UHFFFAOYSA-N 0.000 description 2
- RTICVNQPANONEN-UHFFFAOYSA-N 2-[4-[2-(2-cyclohexyl-5-methyl-1,3-oxazol-4-yl)ethoxy]-3,5-dipropylphenoxy]-2-methylpropanoic acid Chemical compound CCCC1=CC(OC(C)(C)C(O)=O)=CC(CCC)=C1OCCC1=C(C)OC(C2CCCCC2)=N1 RTICVNQPANONEN-UHFFFAOYSA-N 0.000 description 2
- JXVWTRFCAJFTPN-UHFFFAOYSA-N 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-propylphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(CCC)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 JXVWTRFCAJFTPN-UHFFFAOYSA-N 0.000 description 2
- PPAFHWWZYLLESB-UHFFFAOYSA-N 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3-propylphenoxy]acetic acid Chemical compound CCCC1=CC(OCC(O)=O)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 PPAFHWWZYLLESB-UHFFFAOYSA-N 0.000 description 2
- KOLVOIFYLHCUFF-UHFFFAOYSA-N 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]butanoic acid Chemical compound C1=CC(OC(CC)C(O)=O)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 KOLVOIFYLHCUFF-UHFFFAOYSA-N 0.000 description 2
- DKRRJMOXVPKXDO-UHFFFAOYSA-N 2-[4-[2-[2-(4-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound C1=CC(OC)=CC=C1C1=NC(CCOC=2C=CC(OC(C)(C)C(O)=O)=CC=2)=C(C)O1 DKRRJMOXVPKXDO-UHFFFAOYSA-N 0.000 description 2
- OZPGMPJGWWFJIM-UHFFFAOYSA-N 2-but-1-enyl-5-phenylmethoxyphenol Chemical compound C1=C(O)C(C=CCC)=CC=C1OCC1=CC=CC=C1 OZPGMPJGWWFJIM-UHFFFAOYSA-N 0.000 description 2
- YBOCWQVZFUXWNC-UHFFFAOYSA-N 2-ethenyl-4-phenylmethoxyphenol Chemical compound C1=C(C=C)C(O)=CC=C1OCC1=CC=CC=C1 YBOCWQVZFUXWNC-UHFFFAOYSA-N 0.000 description 2
- QIQZAISWDRNIFG-UHFFFAOYSA-N 2-hydroxy-5-phenylmethoxybenzaldehyde Chemical compound C1=C(C=O)C(O)=CC=C1OCC1=CC=CC=C1 QIQZAISWDRNIFG-UHFFFAOYSA-N 0.000 description 2
- ZIRWIUVCGHLWPF-UHFFFAOYSA-N 2-methyl-2-[2-methyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C(C)=C1 ZIRWIUVCGHLWPF-UHFFFAOYSA-N 0.000 description 2
- CYLVJMPIMKAVDC-UHFFFAOYSA-N 2-methyl-2-[4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1COC1=CC=C(OC(C)(C)C(O)=O)C=C1 CYLVJMPIMKAVDC-UHFFFAOYSA-N 0.000 description 2
- XUBRZJBTEMRZEJ-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]naphthalen-1-yl]oxypropanoic acid Chemical compound N=1C(CCOC=2C3=CC=CC=C3C(OC(C)(C)C(O)=O)=CC=2)=C(C)OC=1C1=CC=CC=C1 XUBRZJBTEMRZEJ-UHFFFAOYSA-N 0.000 description 2
- MOXCTWXWOVAJGJ-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-3-phenylpropanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=C1)=CC=C1OC(C)(C(O)=O)CC1=CC=CC=C1 MOXCTWXWOVAJGJ-UHFFFAOYSA-N 0.000 description 2
- DTMFOCXCXAXKMZ-UHFFFAOYSA-N 2-methyl-2-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]propanoic acid Chemical compound N=1C(CCOC=2C=3CCCCC=3C(OC(C)(C)C(O)=O)=CC=2)=C(C)OC=1C1=CC=CC=C1 DTMFOCXCXAXKMZ-UHFFFAOYSA-N 0.000 description 2
- BRIFVTYYOOJQMC-UHFFFAOYSA-N 2-oxido-4,5-dihydro-1,2-oxazol-2-ium Chemical compound [O-][N+]1=CCCO1 BRIFVTYYOOJQMC-UHFFFAOYSA-N 0.000 description 2
- OPOSKIFLSRAORL-UHFFFAOYSA-N 2-phenyl-4-[2-(4-phenylmethoxyphenoxy)ethyl]-1,3-oxazole Chemical compound C=1C=C(OCC=2C=CC=CC=2)C=CC=1OCCC(N=1)=COC=1C1=CC=CC=C1 OPOSKIFLSRAORL-UHFFFAOYSA-N 0.000 description 2
- CCZCXFHJMKINPE-UHFFFAOYSA-N 2-phenylmethoxyphenol Chemical compound OC1=CC=CC=C1OCC1=CC=CC=C1 CCZCXFHJMKINPE-UHFFFAOYSA-N 0.000 description 2
- RPJTXFWBIAEKIV-UHFFFAOYSA-N 3-(5-methyl-2-phenyl-1,3-oxazol-4-yl)prop-2-enoic acid Chemical compound OC(=O)C=CC1=C(C)OC(C=2C=CC=CC=2)=N1 RPJTXFWBIAEKIV-UHFFFAOYSA-N 0.000 description 2
- MSLVOPDTCYPTQE-UHFFFAOYSA-N 3-ethyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenol Chemical compound CCC1=CC(O)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 MSLVOPDTCYPTQE-UHFFFAOYSA-N 0.000 description 2
- ASHGTJPOSUFTGB-UHFFFAOYSA-N 3-methoxyphenol Chemical compound COC1=CC=CC(O)=C1 ASHGTJPOSUFTGB-UHFFFAOYSA-N 0.000 description 2
- RMSKZSBWPMEQLG-UHFFFAOYSA-N 4-[2-(2-cyclohexyl-5-methyl-1,3-oxazol-4-yl)ethoxy]-3,5-dipropylphenol Chemical compound CCCC1=CC(O)=CC(CCC)=C1OCCC1=C(C)OC(C2CCCCC2)=N1 RMSKZSBWPMEQLG-UHFFFAOYSA-N 0.000 description 2
- CGHKLKBJIMFCJH-UHFFFAOYSA-N 4-[2-(2-ethenyl-4-phenylmethoxyphenoxy)ethyl]-5-methyl-2-phenyl-1,3-oxazole Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C(=C1)C=C)=CC=C1OCC1=CC=CC=C1 CGHKLKBJIMFCJH-UHFFFAOYSA-N 0.000 description 2
- OPARKPVQSTYIRI-UHFFFAOYSA-N 4-[2-(2-phenyl-1,3-oxazol-4-yl)ethoxy]phenol Chemical compound C1=CC(O)=CC=C1OCCC1=COC(C=2C=CC=CC=2)=N1 OPARKPVQSTYIRI-UHFFFAOYSA-N 0.000 description 2
- KMNQPORFLOOAGY-UHFFFAOYSA-N 4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3-propylphenol Chemical compound CCCC1=CC(O)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 KMNQPORFLOOAGY-UHFFFAOYSA-N 0.000 description 2
- WJFGEQIUZLHKJL-UHFFFAOYSA-N 4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenol Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC1=CC=C(O)C=C1 WJFGEQIUZLHKJL-UHFFFAOYSA-N 0.000 description 2
- JTDHXDLKJLUYOQ-UHFFFAOYSA-N 4-butyl-3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenol Chemical compound CCCCC1=CC=C(O)C=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 JTDHXDLKJLUYOQ-UHFFFAOYSA-N 0.000 description 2
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 2
- OTDIEZPDMZBEEF-UHFFFAOYSA-N 4-phenylmethoxy-2-prop-2-enylphenol Chemical compound C1=C(CC=C)C(O)=CC=C1OCC1=CC=CC=C1 OTDIEZPDMZBEEF-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- WVEREKGCQGXGQO-UHFFFAOYSA-N 5-methyl-2-phenyl-4-[2-(4-phenylmethoxy-2-propylphenoxy)ethyl]-1,3-oxazole Chemical compound C=1C=C(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)C(CCC)=CC=1OCC1=CC=CC=C1 WVEREKGCQGXGQO-UHFFFAOYSA-N 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 229940123208 Biguanide Drugs 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 208000032928 Dyslipidaemia Diseases 0.000 description 2
- 239000004131 EU approved raising agent Substances 0.000 description 2
- 206010014486 Elevated triglycerides Diseases 0.000 description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 2
- 206010021000 Hypoglycaemic coma Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 208000031773 Insulin resistance syndrome Diseases 0.000 description 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 2
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- 208000017170 Lipid metabolism disease Diseases 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- 102000007399 Nuclear hormone receptor Human genes 0.000 description 2
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 241000183024 Populus tremula Species 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 101100379247 Salmo trutta apoa1 gene Proteins 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical class [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 125000005336 allyloxy group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 239000003529 anticholesteremic agent Substances 0.000 description 2
- 239000003524 antilipemic agent Substances 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- 150000004283 biguanides Chemical class 0.000 description 2
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 125000002837 carbocyclic group Chemical group 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 238000012754 cardiac puncture Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 2
- NHADDZMCASKINP-HTRCEHHLSA-N decarboxydihydrocitrinin Natural products C1=C(O)C(C)=C2[C@H](C)[C@@H](C)OCC2=C1O NHADDZMCASKINP-HTRCEHHLSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 208000010643 digestive system disease Diseases 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- WCPYXMCYGNOEKL-UHFFFAOYSA-N ethyl 2-(2-butyl-5-hydroxyphenoxy)-2-methylpropanoate Chemical compound CCCCC1=CC=C(O)C=C1OC(C)(C)C(=O)OCC WCPYXMCYGNOEKL-UHFFFAOYSA-N 0.000 description 2
- MNGMKQMJUPKVTC-UHFFFAOYSA-N ethyl 2-(2-ethyl-4-hydroxyphenoxy)acetate Chemical compound CCOC(=O)COC1=CC=C(O)C=C1CC MNGMKQMJUPKVTC-UHFFFAOYSA-N 0.000 description 2
- OWPJFZIHRIEWLU-UHFFFAOYSA-N ethyl 2-(2-propyl-4-sulfanylphenoxy)acetate Chemical compound CCCC1=CC(S)=CC=C1OCC(=O)OCC OWPJFZIHRIEWLU-UHFFFAOYSA-N 0.000 description 2
- ITCJAOUTEFUYMX-UHFFFAOYSA-N ethyl 2-(4-hydroxy-2,6-dipropylphenoxy)acetate Chemical compound CCCC1=CC(O)=CC(CCC)=C1OCC(=O)OCC ITCJAOUTEFUYMX-UHFFFAOYSA-N 0.000 description 2
- ZLLUDQCJBVEZTQ-UHFFFAOYSA-N ethyl 2-(4-hydroxy-2-methylphenoxy)-2-methylpropanoate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(O)C=C1C ZLLUDQCJBVEZTQ-UHFFFAOYSA-N 0.000 description 2
- JJHXEWBXGMMWKR-UHFFFAOYSA-N ethyl 2-(4-hydroxy-2-propylphenoxy)acetate Chemical compound CCCC1=CC(O)=CC=C1OCC(=O)OCC JJHXEWBXGMMWKR-UHFFFAOYSA-N 0.000 description 2
- GIQKXFJNJQMNBZ-UHFFFAOYSA-N ethyl 2-(4-hydroxyphenoxy)-2-methyl-3-phenylpropanoate Chemical compound C=1C=C(O)C=CC=1OC(C)(C(=O)OCC)CC1=CC=CC=C1 GIQKXFJNJQMNBZ-UHFFFAOYSA-N 0.000 description 2
- QYBCKYRNAYJTMC-UHFFFAOYSA-N ethyl 2-(4-phenylmethoxy-2-propylphenoxy)acetate Chemical compound C1=C(OCC(=O)OCC)C(CCC)=CC(OCC=2C=CC=CC=2)=C1 QYBCKYRNAYJTMC-UHFFFAOYSA-N 0.000 description 2
- VLBCXJWFERQGDC-UHFFFAOYSA-N ethyl 2-[2-(methoxymethyl)-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=C(COC)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 VLBCXJWFERQGDC-UHFFFAOYSA-N 0.000 description 2
- KPPZCIVGCBGGCR-UHFFFAOYSA-N ethyl 2-[2-butyl-5-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=C(OC(C)(C)C(=O)OCC)C(CCCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 KPPZCIVGCBGGCR-UHFFFAOYSA-N 0.000 description 2
- LXLXAWHVYKGBDA-UHFFFAOYSA-N ethyl 2-[3-ethyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]acetate Chemical compound CCC1=CC(OCC(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 LXLXAWHVYKGBDA-UHFFFAOYSA-N 0.000 description 2
- LKNLJKUCYWDGBL-UHFFFAOYSA-N ethyl 2-[4-(dimethylcarbamothioyloxy)phenoxy]-2-methylpropanoate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(OC(=S)N(C)C)C=C1 LKNLJKUCYWDGBL-UHFFFAOYSA-N 0.000 description 2
- PFIJVNCPBCWWPB-UHFFFAOYSA-N ethyl 2-[4-(dimethylcarbamoylsulfanyl)phenoxy]-2-methylpropanoate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(SC(=O)N(C)C)C=C1 PFIJVNCPBCWWPB-UHFFFAOYSA-N 0.000 description 2
- KTOORXAPSXCTDN-UHFFFAOYSA-N ethyl 2-[4-[2-(2-cyclohexyl-5-methyl-1,3-oxazol-4-yl)ethoxy]-3,5-dipropylphenoxy]-2-methylpropanoate Chemical compound CCCC1=CC(OC(C)(C)C(=O)OCC)=CC(CCC)=C1OCCC1=C(C)OC(C2CCCCC2)=N1 KTOORXAPSXCTDN-UHFFFAOYSA-N 0.000 description 2
- FABOMKKFSUJCBY-UHFFFAOYSA-N ethyl 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3-propylphenoxy]acetate Chemical compound CCCC1=CC(OCC(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 FABOMKKFSUJCBY-UHFFFAOYSA-N 0.000 description 2
- APTVEVVFCDNLHU-UHFFFAOYSA-N ethyl 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]butanoate Chemical compound C1=CC(OC(CC)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 APTVEVVFCDNLHU-UHFFFAOYSA-N 0.000 description 2
- KACPRLFETONVKG-UHFFFAOYSA-N ethyl 2-[4-[2-[2-(3-ethynylphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=C(C=CC=2)C#C)=N1 KACPRLFETONVKG-UHFFFAOYSA-N 0.000 description 2
- LGCORTSOJJZQBF-UHFFFAOYSA-N ethyl 2-[4-[2-[2-(4-carbamoylphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC(=CC=2)C(N)=O)=N1 LGCORTSOJJZQBF-UHFFFAOYSA-N 0.000 description 2
- ODBSISTYHNAKSH-UHFFFAOYSA-N ethyl 2-[4-butyl-3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoate Chemical compound CCCCC1=CC=C(OC(C)(C)C(=O)OCC)C=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 ODBSISTYHNAKSH-UHFFFAOYSA-N 0.000 description 2
- HBUCOJJHCABBQI-UHFFFAOYSA-N ethyl 2-[4-hydroxy-2-(hydroxymethyl)phenoxy]-2-methylpropanoate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(O)C=C1CO HBUCOJJHCABBQI-UHFFFAOYSA-N 0.000 description 2
- DNLHNAUIWJZGSA-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCC1=C(C)OC(C=2C=CC=CC=2)=N1 DNLHNAUIWJZGSA-UHFFFAOYSA-N 0.000 description 2
- FYZYNRUFIWSQFP-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-(2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=COC(C=2C=CC=CC=2)=N1 FYZYNRUFIWSQFP-UHFFFAOYSA-N 0.000 description 2
- SVNQMPPDQRZYRZ-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3,5-dipropylphenoxy]propanoate Chemical compound CCCC1=CC(OC(C)(C)C(=O)OCC)=CC(CCC)=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 SVNQMPPDQRZYRZ-UHFFFAOYSA-N 0.000 description 2
- WFHYCYDYVMTGAC-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-[5-methyl-2-[3-(2-methylphenoxy)phenyl]-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=C(OC=3C(=CC=CC=3)C)C=CC=2)=N1 WFHYCYDYVMTGAC-UHFFFAOYSA-N 0.000 description 2
- LHMWUMZNRNUHEQ-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-[5-methyl-2-[3-(2-phenylethynyl)phenyl]-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=C(C=CC=2)C#CC=2C=CC=CC=2)=N1 LHMWUMZNRNUHEQ-UHFFFAOYSA-N 0.000 description 2
- ILXSHRXIUKVNCE-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-[5-methyl-2-[4-(2-phenylethynyl)phenyl]-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC(=CC=2)C#CC=2C=CC=CC=2)=N1 ILXSHRXIUKVNCE-UHFFFAOYSA-N 0.000 description 2
- WKCDQJDPPMHFTD-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-[5-methyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC(=CC=2)B2OC(C)(C)C(C)(C)O2)=N1 WKCDQJDPPMHFTD-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000001030 gas--liquid chromatography Methods 0.000 description 2
- 208000018685 gastrointestinal system disease Diseases 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 230000003345 hyperglycaemic effect Effects 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 229960002725 isoflurane Drugs 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 2
- PCILLCXFKWDRMK-UHFFFAOYSA-N naphthalene-1,4-diol Chemical compound C1=CC=C2C(O)=CC=C(O)C2=C1 PCILLCXFKWDRMK-UHFFFAOYSA-N 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 125000006574 non-aromatic ring group Chemical group 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000004533 oil dispersion Substances 0.000 description 2
- 238000003305 oral gavage Methods 0.000 description 2
- 125000003145 oxazol-4-yl group Chemical group O1C=NC(=C1)* 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- UXCDUFKZSUBXGM-UHFFFAOYSA-N phosphoric tribromide Chemical compound BrP(Br)(Br)=O UXCDUFKZSUBXGM-UHFFFAOYSA-N 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 2
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 238000011830 transgenic mouse model Methods 0.000 description 2
- PYMPTRMDPJYTDF-UHFFFAOYSA-N tributyl(2-phenylethynyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C#CC1=CC=CC=C1 PYMPTRMDPJYTDF-UHFFFAOYSA-N 0.000 description 2
- YEMJHNYABQHWHL-UHFFFAOYSA-N tributyl(ethynyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C#C YEMJHNYABQHWHL-UHFFFAOYSA-N 0.000 description 2
- 229940086542 triethylamine Drugs 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- PCTMTFRHKVHKIS-BMFZQQSSSA-N (1s,3r,4e,6e,8e,10e,12e,14e,16e,18s,19r,20r,21s,25r,27r,30r,31r,33s,35r,37s,38r)-3-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10 Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2.O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 PCTMTFRHKVHKIS-BMFZQQSSSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- ADPCXNNAJIWPEH-OISQWLRKSA-N (4r,4ar,7s,7ar,12bs)-8a-(2-chloroethyl)-3-methyl-1,2,4,4a,7,7a,9,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol;hydrochloride Chemical compound Cl.O[C@H]([C@@H]1OC2(CCCl)C(O)C=C3)C=C[C@H]4[C@]5([H])N(C)CC[C@@]41C2=C3C5 ADPCXNNAJIWPEH-OISQWLRKSA-N 0.000 description 1
- AAQIALLSQXGHHT-UHFFFAOYSA-N (5-methyl-2-phenyl-1,3-oxazol-4-yl)methanol Chemical compound OCC1=C(C)OC(C=2C=CC=CC=2)=N1 AAQIALLSQXGHHT-UHFFFAOYSA-N 0.000 description 1
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 1
- SHCFCJUJGBRSPO-UHFFFAOYSA-N 1-cyclohexylcyclohexan-1-amine Chemical compound C1CCCCC1C1(N)CCCCC1 SHCFCJUJGBRSPO-UHFFFAOYSA-N 0.000 description 1
- ANOOTOPTCJRUPK-UHFFFAOYSA-N 1-iodohexane Chemical compound CCCCCCI ANOOTOPTCJRUPK-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- AHDSRXYHVZECER-UHFFFAOYSA-N 2,4,6-tris[(dimethylamino)methyl]phenol Chemical compound CN(C)CC1=CC(CN(C)C)=C(O)C(CN(C)C)=C1 AHDSRXYHVZECER-UHFFFAOYSA-N 0.000 description 1
- AMIDWHFZNWGIIQ-UHFFFAOYSA-N 2-(2-phenyl-1,3-oxazol-4-yl)ethanol Chemical compound OCCC1=COC(C=2C=CC=CC=2)=N1 AMIDWHFZNWGIIQ-UHFFFAOYSA-N 0.000 description 1
- YBLSZTNTTGNGJN-UHFFFAOYSA-N 2-(2-phenyl-5-propyl-1,3-oxazol-4-yl)ethanol Chemical compound OCCC1=C(CCC)OC(C=2C=CC=CC=2)=N1 YBLSZTNTTGNGJN-UHFFFAOYSA-N 0.000 description 1
- YVSCNCDVQOXQAG-UHFFFAOYSA-N 2-(3-bromophenyl)-4,5-dimethyl-3-oxido-1,3-oxazol-3-ium Chemical compound CC1=C(C)OC(C=2C=C(Br)C=CC=2)=[N+]1[O-] YVSCNCDVQOXQAG-UHFFFAOYSA-N 0.000 description 1
- RWJANIVLWJJYFC-UHFFFAOYSA-N 2-(3-bromophenyl)-4-(chloromethyl)-5-methyl-1,3-oxazole Chemical compound ClCC1=C(C)OC(C=2C=C(Br)C=CC=2)=N1 RWJANIVLWJJYFC-UHFFFAOYSA-N 0.000 description 1
- VAZIKQTXCVKZOA-UHFFFAOYSA-N 2-(4-bromophenyl)-4-ethenyl-5-methyl-1,3-oxazole Chemical compound C=CC1=C(C)OC(C=2C=CC(Br)=CC=2)=N1 VAZIKQTXCVKZOA-UHFFFAOYSA-N 0.000 description 1
- ATPBADOREFXKFS-UHFFFAOYSA-N 2-(4-phenylmethoxyphenoxy)propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OCC1=CC=CC=C1 ATPBADOREFXKFS-UHFFFAOYSA-N 0.000 description 1
- SZYXURFSAUXFNT-UHFFFAOYSA-N 2-(5-methyl-2-phenyl-1,3-thiazol-4-yl)acetic acid Chemical compound OC(=O)CC1=C(C)SC(C=2C=CC=CC=2)=N1 SZYXURFSAUXFNT-UHFFFAOYSA-N 0.000 description 1
- OCDDKCLHRXAOFF-UHFFFAOYSA-N 2-(5-methyl-2-thiophen-2-yl-1,3-oxazol-4-yl)acetic acid Chemical compound OC(=O)CC1=C(C)OC(C=2SC=CC=2)=N1 OCDDKCLHRXAOFF-UHFFFAOYSA-N 0.000 description 1
- KOYCQWXFCNCUSM-UHFFFAOYSA-N 2-(5-methyl-2-thiophen-2-yl-1,3-oxazol-4-yl)acetonitrile Chemical compound N#CCC1=C(C)OC(C=2SC=CC=2)=N1 KOYCQWXFCNCUSM-UHFFFAOYSA-N 0.000 description 1
- ZHZFRBCGENPVGT-UHFFFAOYSA-N 2-(5-methyl-2-thiophen-2-yl-1,3-oxazol-4-yl)ethyl 4-methylbenzenesulfonate Chemical compound CC=1OC(C=2SC=CC=2)=NC=1CCOS(=O)(=O)C1=CC=C(C)C=C1 ZHZFRBCGENPVGT-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- WVWVSAXKJDDNKO-UHFFFAOYSA-N 2-[2-(3-bromophenyl)-5-methyl-1,3-oxazol-4-yl]acetic acid Chemical compound OC(=O)CC1=C(C)OC(C=2C=C(Br)C=CC=2)=N1 WVWVSAXKJDDNKO-UHFFFAOYSA-N 0.000 description 1
- ZXYNLFBHWXBVBA-UHFFFAOYSA-N 2-[2-(3-bromophenyl)-5-methyl-1,3-oxazol-4-yl]acetonitrile Chemical compound N#CCC1=C(C)OC(C=2C=C(Br)C=CC=2)=N1 ZXYNLFBHWXBVBA-UHFFFAOYSA-N 0.000 description 1
- IFZLDHGXXPGFFK-UHFFFAOYSA-N 2-[2-(3-bromophenyl)-5-methyl-1,3-oxazol-4-yl]ethanol Chemical compound OCCC1=C(C)OC(C=2C=C(Br)C=CC=2)=N1 IFZLDHGXXPGFFK-UHFFFAOYSA-N 0.000 description 1
- KOADNYOMLAWJOE-UHFFFAOYSA-N 2-[2-(3-bromophenyl)-5-methyl-1,3-oxazol-4-yl]ethyl 4-methylbenzenesulfonate Chemical compound CC=1OC(C=2C=C(Br)C=CC=2)=NC=1CCOS(=O)(=O)C1=CC=C(C)C=C1 KOADNYOMLAWJOE-UHFFFAOYSA-N 0.000 description 1
- DSBZBXSHVDFZLL-UHFFFAOYSA-N 2-[2-(cyclohexylmethyl)-4-[2-(2-cyclohexyl-5-methyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C2CCCCC2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1CC1CCCCC1 DSBZBXSHVDFZLL-UHFFFAOYSA-N 0.000 description 1
- YIYXOQWTRTZUOA-UHFFFAOYSA-N 2-[2-(cyclohexylmethyl)-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1CC1CCCCC1 YIYXOQWTRTZUOA-UHFFFAOYSA-N 0.000 description 1
- JPNBENCGCPDWQP-UHFFFAOYSA-N 2-[2-(methoxymethyl)-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound C1=C(OC(C)(C)C(O)=O)C(COC)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 JPNBENCGCPDWQP-UHFFFAOYSA-N 0.000 description 1
- JAVVFQJPXGSWSG-UHFFFAOYSA-N 2-[2-[(4-methoxyphenoxy)methyl]-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound C1=CC(OC)=CC=C1OCC1=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=CC=C1OC(C)(C)C(O)=O JAVVFQJPXGSWSG-UHFFFAOYSA-N 0.000 description 1
- PITWECJMKAWIID-UHFFFAOYSA-N 2-[2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]phenyl]acetic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=C1)=CC=C1OC1=CC=CC=C1CC(O)=O PITWECJMKAWIID-UHFFFAOYSA-N 0.000 description 1
- ADNGSMXCVXRWAR-UHFFFAOYSA-N 2-[2-benzyl-4-[2-(2-cyclohexyl-5-methyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C2CCCCC2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1CC1=CC=CC=C1 ADNGSMXCVXRWAR-UHFFFAOYSA-N 0.000 description 1
- YINJZZTWEOKZBP-UHFFFAOYSA-N 2-[2-benzyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1CC1=CC=CC=C1 YINJZZTWEOKZBP-UHFFFAOYSA-N 0.000 description 1
- AWZTZXDXPGIYHK-UHFFFAOYSA-N 2-[2-butyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound C1=C(OC(C)(C)C(O)=O)C(CCCC)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 AWZTZXDXPGIYHK-UHFFFAOYSA-N 0.000 description 1
- BWNJBNZFDWAVDJ-UHFFFAOYSA-N 2-[2-butyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(CCCC)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 BWNJBNZFDWAVDJ-UHFFFAOYSA-N 0.000 description 1
- IORPCFVCUZLEJS-UHFFFAOYSA-N 2-[2-ethyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound C1=C(OC(C)(C)C(O)=O)C(CC)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 IORPCFVCUZLEJS-UHFFFAOYSA-N 0.000 description 1
- SHYZSWVSTLYMJT-UHFFFAOYSA-N 2-[2-methyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]acetic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC1=CC=C(OCC(O)=O)C(C)=C1 SHYZSWVSTLYMJT-UHFFFAOYSA-N 0.000 description 1
- PQWNJNFLUUPCMA-UHFFFAOYSA-N 2-[3-butyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CCCCC1=CC(OC(C)(C)C(O)=O)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 PQWNJNFLUUPCMA-UHFFFAOYSA-N 0.000 description 1
- MSBWDLPSIPOFOJ-UHFFFAOYSA-N 2-[3-ethyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CCC1=CC(OC(C)(C)C(O)=O)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 MSBWDLPSIPOFOJ-UHFFFAOYSA-N 0.000 description 1
- IAQFIAYBLZPBEA-UHFFFAOYSA-N 2-[3-ethyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]acetic acid Chemical compound CCC1=CC(OCC(O)=O)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 IAQFIAYBLZPBEA-UHFFFAOYSA-N 0.000 description 1
- VZPYIDVETWWRCI-UHFFFAOYSA-N 2-[4-[2-(2-cyclohexyl-5-methyl-1,3-oxazol-4-yl)ethoxy]-2-(2-phenylethyl)phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C2CCCCC2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1CCC1=CC=CC=C1 VZPYIDVETWWRCI-UHFFFAOYSA-N 0.000 description 1
- UGUYEPJZXWYYEV-UHFFFAOYSA-N 2-[4-[2-(2-cyclohexyl-5-methyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C2CCCCC2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 UGUYEPJZXWYYEV-UHFFFAOYSA-N 0.000 description 1
- OOKNUTVJTBZODD-UHFFFAOYSA-N 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2,6-dipropylphenoxy]acetic acid Chemical compound CCCC1=C(OCC(O)=O)C(CCC)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 OOKNUTVJTBZODD-UHFFFAOYSA-N 0.000 description 1
- JOYNUKGXSPPLQG-UHFFFAOYSA-N 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-(5-phenylpentyl)phenoxy]acetic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=1)=CC=C(OCC(O)=O)C=1CCCCCC1=CC=CC=C1 JOYNUKGXSPPLQG-UHFFFAOYSA-N 0.000 description 1
- MZLNLBUIXIGHAW-UHFFFAOYSA-N 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3-(2-methylpropyl)phenoxy]acetic acid Chemical compound CC(C)CC1=CC(OCC(O)=O)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 MZLNLBUIXIGHAW-UHFFFAOYSA-N 0.000 description 1
- XUVUMHVCGITREU-UHFFFAOYSA-N 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3-(5-phenylpentyl)phenoxy]acetic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC1=CC=C(OCC(O)=O)C=C1CCCCCC1=CC=CC=C1 XUVUMHVCGITREU-UHFFFAOYSA-N 0.000 description 1
- NCGSRUIHTLREIE-UHFFFAOYSA-N 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]acetic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC1=CC=C(OCC(O)=O)C=C1 NCGSRUIHTLREIE-UHFFFAOYSA-N 0.000 description 1
- CLZLENJZBSHFMY-UHFFFAOYSA-N 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]dodecanoic acid Chemical compound C1=CC(OC(CCCCCCCCCC)C(O)=O)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 CLZLENJZBSHFMY-UHFFFAOYSA-N 0.000 description 1
- PIWIBPTWFPRGCD-UHFFFAOYSA-N 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]hexanoic acid Chemical compound C1=CC(OC(CCCC)C(O)=O)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 PIWIBPTWFPRGCD-UHFFFAOYSA-N 0.000 description 1
- OZDZILRXVNZBAD-UHFFFAOYSA-N 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]octanoic acid Chemical compound C1=CC(OC(CCCCCC)C(O)=O)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 OZDZILRXVNZBAD-UHFFFAOYSA-N 0.000 description 1
- ZBKLXHAHCJHQOK-UHFFFAOYSA-N 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 ZBKLXHAHCJHQOK-UHFFFAOYSA-N 0.000 description 1
- IFBNBNQZLAZEHD-UHFFFAOYSA-N 2-[4-[2-[2-(3-bromophenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C=2C=C(Br)C=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 IFBNBNQZLAZEHD-UHFFFAOYSA-N 0.000 description 1
- ARFXJKYASRFHBN-UHFFFAOYSA-N 2-[4-[2-[2-(3-ethenylphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C=2C=C(C=C)C=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 ARFXJKYASRFHBN-UHFFFAOYSA-N 0.000 description 1
- ACIGJJCDYOQKLD-UHFFFAOYSA-N 2-[4-[2-[2-(3-ethylphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CCC1=CC=CC(C=2OC(C)=C(CCOC=3C=CC(OC(C)(C)C(O)=O)=CC=3)N=2)=C1 ACIGJJCDYOQKLD-UHFFFAOYSA-N 0.000 description 1
- PNBGUACPXRVYPF-UHFFFAOYSA-N 2-[4-[2-[2-(3-ethynylphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C=2C=C(C=CC=2)C#C)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 PNBGUACPXRVYPF-UHFFFAOYSA-N 0.000 description 1
- XQCVRZOYMZKHMY-UHFFFAOYSA-N 2-[4-[2-[2-(4-bromophenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid;ethyl 2-[4-[2-[2-(4-bromophenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound CC=1OC(C=2C=CC(Br)=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1.C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC(Br)=CC=2)=N1 XQCVRZOYMZKHMY-UHFFFAOYSA-N 0.000 description 1
- DLNBVQPVTRBJBJ-UHFFFAOYSA-N 2-[4-[2-[2-(4-carbamoylphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C=2C=CC(=CC=2)C(N)=O)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 DLNBVQPVTRBJBJ-UHFFFAOYSA-N 0.000 description 1
- OSKHMPCMVNUFPC-UHFFFAOYSA-N 2-[4-[2-[2-(4-ethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound C1=CC(OCC)=CC=C1C1=NC(CCOC=2C=CC(OC(C)(C)C(O)=O)=CC=2)=C(C)O1 OSKHMPCMVNUFPC-UHFFFAOYSA-N 0.000 description 1
- HXBVPLNCWXWGIR-UHFFFAOYSA-N 2-[4-[2-[2-(4-ethylphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound C1=CC(CC)=CC=C1C1=NC(CCOC=2C=CC(OC(C)(C)C(O)=O)=CC=2)=C(C)O1 HXBVPLNCWXWGIR-UHFFFAOYSA-N 0.000 description 1
- HZRILARTYODWIY-UHFFFAOYSA-N 2-[4-[2-[2-(4-hexoxyphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound C1=CC(OCCCCCC)=CC=C1C1=NC(CCOC=2C=CC(OC(C)(C)C(O)=O)=CC=2)=C(C)O1 HZRILARTYODWIY-UHFFFAOYSA-N 0.000 description 1
- OFWCAORVNSNTFT-UHFFFAOYSA-N 2-[4-[2-[2-[4-(2-methoxyphenoxy)phenyl]-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound COC1=CC=CC=C1OC1=CC=C(C=2OC(C)=C(CCOC=3C=CC(OC(C)(C)C(O)=O)=CC=3)N=2)C=C1 OFWCAORVNSNTFT-UHFFFAOYSA-N 0.000 description 1
- AWNQDWPXKSQUBN-UHFFFAOYSA-N 2-[4-[2-[2-[4-(3-tert-butylphenoxy)phenyl]-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CC=1OC(C=2C=CC(OC=3C=C(C=CC=3)C(C)(C)C)=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 AWNQDWPXKSQUBN-UHFFFAOYSA-N 0.000 description 1
- QQVIWGMCUGNNSS-UHFFFAOYSA-N 2-[4-[2-[2-[4-(4-methoxyphenoxy)phenyl]-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound C1=CC(OC)=CC=C1OC1=CC=C(C=2OC(C)=C(CCOC=3C=CC(OC(C)(C)C(O)=O)=CC=3)N=2)C=C1 QQVIWGMCUGNNSS-UHFFFAOYSA-N 0.000 description 1
- NMOZQJGJJUGFLY-UHFFFAOYSA-N 2-[4-butyl-3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CCCCC1=CC=C(OC(C)(C)C(O)=O)C=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 NMOZQJGJJUGFLY-UHFFFAOYSA-N 0.000 description 1
- BEYNUIXFDWWHLG-UHFFFAOYSA-N 2-[5-[2-(2-cyclohexyl-5-methyl-1,3-oxazol-4-yl)ethoxy]-2-propylphenoxy]-2-methylpropanoic acid Chemical compound C1=C(OC(C)(C)C(O)=O)C(CCC)=CC=C1OCCC1=C(C)OC(C2CCCCC2)=N1 BEYNUIXFDWWHLG-UHFFFAOYSA-N 0.000 description 1
- FCZWKCUGEUATRA-UHFFFAOYSA-N 2-[5-methyl-2-(4-phenylmethoxyphenyl)-1,3-oxazol-4-yl]ethanol Chemical compound OCCC1=C(C)OC(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)=N1 FCZWKCUGEUATRA-UHFFFAOYSA-N 0.000 description 1
- RKLSWVUULKUJJF-UHFFFAOYSA-N 2-[hydroxy(phenyl)methyl]-4-phenylmethoxyphenol Chemical compound C=1C(OCC=2C=CC=CC=2)=CC=C(O)C=1C(O)C1=CC=CC=C1 RKLSWVUULKUJJF-UHFFFAOYSA-N 0.000 description 1
- QIRNGVVZBINFMX-UHFFFAOYSA-N 2-allylphenol Chemical compound OC1=CC=CC=C1CC=C QIRNGVVZBINFMX-UHFFFAOYSA-N 0.000 description 1
- YAQLSKVCTLCIIE-UHFFFAOYSA-N 2-bromobutyric acid Chemical compound CCC(Br)C(O)=O YAQLSKVCTLCIIE-UHFFFAOYSA-N 0.000 description 1
- YGCDEKDMMJNNTJ-UHFFFAOYSA-N 2-but-1-enyl-5-phenylmethoxyphenol;ethyl 2-(2-but-1-enyl-5-phenylmethoxyphenoxy)-2-methylpropanoate Chemical compound C1=C(O)C(C=CCC)=CC=C1OCC1=CC=CC=C1.C1=C(C=CCC)C(OC(C)(C)C(=O)OCC)=CC(OCC=2C=CC=CC=2)=C1 YGCDEKDMMJNNTJ-UHFFFAOYSA-N 0.000 description 1
- MGUYYKCIMYXOAD-UHFFFAOYSA-N 2-ethenyl-4-phenylmethoxyphenol;ethyl 2-(2-ethenyl-4-phenylmethoxyphenoxy)acetate Chemical compound C1=C(C=C)C(O)=CC=C1OCC1=CC=CC=C1.C1=C(C=C)C(OCC(=O)OCC)=CC=C1OCC1=CC=CC=C1 MGUYYKCIMYXOAD-UHFFFAOYSA-N 0.000 description 1
- IDQPYNNNKOORPJ-UHFFFAOYSA-N 2-hydroxy-3-phenylmethoxybenzaldehyde Chemical compound C1=CC=C(C=O)C(O)=C1OCC1=CC=CC=C1 IDQPYNNNKOORPJ-UHFFFAOYSA-N 0.000 description 1
- AMLKEDBYDOCGEG-UHFFFAOYSA-N 2-hydroxy-4-phenylmethoxybenzaldehyde Chemical compound C1=C(C=O)C(O)=CC(OCC=2C=CC=CC=2)=C1 AMLKEDBYDOCGEG-UHFFFAOYSA-N 0.000 description 1
- 102100027324 2-hydroxyacyl-CoA lyase 1 Human genes 0.000 description 1
- 125000006179 2-methyl benzyl group Chemical group [H]C1=C([H])C(=C(C([H])=C1[H])C([H])([H])*)C([H])([H])[H] 0.000 description 1
- SPELSBKXHKRFER-UHFFFAOYSA-N 2-methyl-2-[4-[2-(2-phenyl-5-propyl-1,3-oxazol-4-yl)ethoxy]phenoxy]propanoic acid Chemical compound CCCC=1OC(C=2C=CC=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 SPELSBKXHKRFER-UHFFFAOYSA-N 0.000 description 1
- YSWVRLGJGRLGJT-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-(2-methylpropyl)phenoxy]propanoic acid Chemical compound C1=C(OC(C)(C)C(O)=O)C(CC(C)C)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 YSWVRLGJGRLGJT-UHFFFAOYSA-N 0.000 description 1
- QDGWHDSJCWHKSD-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-(2-phenylethyl)phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1CCC1=CC=CC=C1 QDGWHDSJCWHKSD-UHFFFAOYSA-N 0.000 description 1
- OMKBKPDRWZXFPS-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-(5-phenylpentyl)phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1CCCCCC1=CC=CC=C1 OMKBKPDRWZXFPS-UHFFFAOYSA-N 0.000 description 1
- KWXJSGUSPQJJBB-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-[[4-(trifluoromethyl)phenoxy]methyl]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=1)=CC=C(OC(C)(C)C(O)=O)C=1COC1=CC=C(C(F)(F)F)C=C1 KWXJSGUSPQJJBB-UHFFFAOYSA-N 0.000 description 1
- GRHIHUVNGNHOIU-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-propylphenoxy]propanoic acid Chemical compound C1=C(OC(C)(C)C(O)=O)C(CCC)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 GRHIHUVNGNHOIU-UHFFFAOYSA-N 0.000 description 1
- ICQQQCNXCVXVFZ-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3-(5-phenylpentyl)phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1CCCCCC1=CC=CC=C1 ICQQQCNXCVXVFZ-UHFFFAOYSA-N 0.000 description 1
- DFZNFXDXKHOPFG-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3-propylphenoxy]propanoic acid Chemical compound CCCC1=CC(OC(C)(C)C(O)=O)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 DFZNFXDXKHOPFG-UHFFFAOYSA-N 0.000 description 1
- DBLOTXLMFNXDEW-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 DBLOTXLMFNXDEW-UHFFFAOYSA-N 0.000 description 1
- SXTPRTJDRDLETC-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethylsulfanyl]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCSC1=CC=C(OC(C)(C)C(O)=O)C=C1 SXTPRTJDRDLETC-UHFFFAOYSA-N 0.000 description 1
- JEEXEHQDRXGLRS-UHFFFAOYSA-N 2-methyl-2-[4-[2-[5-methyl-2-(4-phenylmethoxyphenyl)-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 JEEXEHQDRXGLRS-UHFFFAOYSA-N 0.000 description 1
- OTICETCCTNUQAH-UHFFFAOYSA-N 2-methyl-2-[4-[2-[5-methyl-2-(4-propan-2-yloxyphenyl)-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoic acid Chemical compound C1=CC(OC(C)C)=CC=C1C1=NC(CCOC=2C=CC(OC(C)(C)C(O)=O)=CC=2)=C(C)O1 OTICETCCTNUQAH-UHFFFAOYSA-N 0.000 description 1
- NSFUFFNWSVDSPP-UHFFFAOYSA-N 2-methyl-2-[4-[2-[5-methyl-2-(4-propoxyphenyl)-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoic acid Chemical compound C1=CC(OCCC)=CC=C1C1=NC(CCOC=2C=CC(OC(C)(C)C(O)=O)=CC=2)=C(C)O1 NSFUFFNWSVDSPP-UHFFFAOYSA-N 0.000 description 1
- HQSARRBAVKGPNH-UHFFFAOYSA-N 2-methyl-2-[4-[2-[5-methyl-2-[3-(2-phenylethyl)phenyl]-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=C(CCC=3C=CC=CC=3)C=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 HQSARRBAVKGPNH-UHFFFAOYSA-N 0.000 description 1
- HULDTOFVLBGXKF-UHFFFAOYSA-N 2-methyl-2-[4-[2-[5-methyl-2-[3-(2-phenylethynyl)phenyl]-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=C(C=CC=2)C#CC=2C=CC=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 HULDTOFVLBGXKF-UHFFFAOYSA-N 0.000 description 1
- WEWRCBMWXJEDDW-UHFFFAOYSA-N 2-methyl-2-[4-[2-[5-methyl-2-[4-(2-phenylethynyl)phenyl]-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC(=CC=2)C#CC=2C=CC=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 WEWRCBMWXJEDDW-UHFFFAOYSA-N 0.000 description 1
- NRMDUCOCAIFKGA-UHFFFAOYSA-N 2-methyl-2-[4-[2-[5-methyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC(=CC=2)B2OC(C)(C)C(C)(C)O2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 NRMDUCOCAIFKGA-UHFFFAOYSA-N 0.000 description 1
- ZQHCQMYARVWJFW-UHFFFAOYSA-N 2-methyl-2-[4-[2-[5-methyl-2-[4-(oxan-4-yloxy)phenyl]-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC(OC3CCOCC3)=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 ZQHCQMYARVWJFW-UHFFFAOYSA-N 0.000 description 1
- GKEIRTZAAAEWOB-UHFFFAOYSA-N 2-methyl-2-[4-[2-[5-methyl-2-[4-[4-(trifluoromethyl)phenoxy]phenyl]-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=CC(OC=3C=CC(=CC=3)C(F)(F)F)=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1 GKEIRTZAAAEWOB-UHFFFAOYSA-N 0.000 description 1
- RXEYOGMNOPCNSM-UHFFFAOYSA-N 2-methyl-2-[5-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-propylphenoxy]propanoic acid Chemical compound C1=C(OC(C)(C)C(O)=O)C(CCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 RXEYOGMNOPCNSM-UHFFFAOYSA-N 0.000 description 1
- ILPUOPPYSQEBNJ-UHFFFAOYSA-N 2-methyl-2-phenoxypropanoic acid Chemical compound OC(=O)C(C)(C)OC1=CC=CC=C1 ILPUOPPYSQEBNJ-UHFFFAOYSA-N 0.000 description 1
- YHOAWPZAIDNVAE-UHFFFAOYSA-N 2-methyl-3-phenyl-2-(4-phenylmethoxyphenoxy)propanoic acid Chemical compound C=1C=C(OCC=2C=CC=CC=2)C=CC=1OC(C(O)=O)(C)CC1=CC=CC=C1 YHOAWPZAIDNVAE-UHFFFAOYSA-N 0.000 description 1
- GNLCHPAOQGOKPD-UHFFFAOYSA-N 2-phenyl-4-(2-phenylmethoxyethyl)-1,3-oxazole Chemical compound C=1C=CC=CC=1COCCC(N=1)=COC=1C1=CC=CC=C1 GNLCHPAOQGOKPD-UHFFFAOYSA-N 0.000 description 1
- 125000006494 2-trifluoromethyl benzyl group Chemical group [H]C1=C([H])C([H])=C(C(=C1[H])C([H])([H])*)C(F)(F)F 0.000 description 1
- VLSHCTWROMVKJD-UHFFFAOYSA-N 3-[2-(cyclohexylcarbamoyloxymethyl)-4-[2-(2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanoic acid Chemical compound C1=C(COC(=O)NC2CCCCC2)C(CCC(=O)O)=CC=C1OCCC(N=1)=COC=1C1=CC=CC=C1 VLSHCTWROMVKJD-UHFFFAOYSA-N 0.000 description 1
- SUISZCALMBHJQX-UHFFFAOYSA-N 3-bromobenzaldehyde Chemical compound BrC1=CC=CC(C=O)=C1 SUISZCALMBHJQX-UHFFFAOYSA-N 0.000 description 1
- 125000006497 3-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1[H])C([H])([H])* 0.000 description 1
- 125000006180 3-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])[H])C([H])([H])* 0.000 description 1
- VFRFHNQJTRHGKQ-UHFFFAOYSA-N 3-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]butanoic acid Chemical compound C1=CC(OC(C(C)C)C(O)=O)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 VFRFHNQJTRHGKQ-UHFFFAOYSA-N 0.000 description 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- IYTJRMRETHPZAC-UHFFFAOYSA-N 4,4-dibenzylpiperidine Chemical compound C1CNCCC1(CC=1C=CC=CC=1)CC1=CC=CC=C1 IYTJRMRETHPZAC-UHFFFAOYSA-N 0.000 description 1
- WQOQSIHHMNWGBB-UHFFFAOYSA-N 4,5-dimethyl-3-oxido-2-(4-phenylmethoxyphenyl)-1,3-oxazol-3-ium Chemical compound CC1=C(C)OC(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)=[N+]1[O-] WQOQSIHHMNWGBB-UHFFFAOYSA-N 0.000 description 1
- FCNFIIPOWDZZLJ-UHFFFAOYSA-N 4-(chloromethyl)-5-methyl-2-(4-phenylmethoxyphenyl)-1,3-oxazole Chemical compound ClCC1=C(C)OC(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)=N1 FCNFIIPOWDZZLJ-UHFFFAOYSA-N 0.000 description 1
- UWKSFZMISAANMN-UHFFFAOYSA-N 4-(chloromethyl)-5-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-oxazole Chemical compound ClCC1=C(C)OC(C=2C=CC(=CC=2)C(F)(F)F)=N1 UWKSFZMISAANMN-UHFFFAOYSA-N 0.000 description 1
- BAYGVMXZJBFEMB-UHFFFAOYSA-N 4-(trifluoromethyl)phenol Chemical compound OC1=CC=C(C(F)(F)F)C=C1 BAYGVMXZJBFEMB-UHFFFAOYSA-N 0.000 description 1
- AQDNYAVMYREBDD-UHFFFAOYSA-N 4-[2-(2-but-1-enyl-5-phenylmethoxyphenoxy)ethyl]-5-methyl-2-phenyl-1,3-oxazole Chemical compound C1=C(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)C(C=CCC)=CC=C1OCC1=CC=CC=C1 AQDNYAVMYREBDD-UHFFFAOYSA-N 0.000 description 1
- FOQHLFIGIZCZLB-UHFFFAOYSA-N 4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3,5-dipropylphenol Chemical compound CCCC1=CC(O)=CC(CCC)=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 FOQHLFIGIZCZLB-UHFFFAOYSA-N 0.000 description 1
- ZRYZBQLXDKPBDU-UHFFFAOYSA-N 4-bromobenzaldehyde Chemical compound BrC1=CC=C(C=O)C=C1 ZRYZBQLXDKPBDU-UHFFFAOYSA-N 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 1
- JCLFHZLOKITRCE-UHFFFAOYSA-N 4-pentoxyphenol Chemical compound CCCCCOC1=CC=C(O)C=C1 JCLFHZLOKITRCE-UHFFFAOYSA-N 0.000 description 1
- 125000006189 4-phenyl benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- ZVTWZSXLLMNMQC-UHFFFAOYSA-N 4-phenylmethoxybenzaldehyde Chemical compound C1=CC(C=O)=CC=C1OCC1=CC=CC=C1 ZVTWZSXLLMNMQC-UHFFFAOYSA-N 0.000 description 1
- 125000001318 4-trifluoromethylbenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(F)(F)F 0.000 description 1
- OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 1
- JEXONSMPSXTJFF-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-oxazole-4-carbaldehyde Chemical compound O=CC1=C(C)OC(C=2C=CC=CC=2)=N1 JEXONSMPSXTJFF-UHFFFAOYSA-N 0.000 description 1
- YHYDPZJTQRXLMN-UHFFFAOYSA-N 5-methyl-2-phenyl-4-[2-(4-phenylmethoxyphenoxy)ethyl]-1,3-oxazole Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CCOC(C=C1)=CC=C1OCC1=CC=CC=C1 YHYDPZJTQRXLMN-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- AHNMPDNEZXLGPS-UHFFFAOYSA-N C(C)OC(COC1=C(C=C(C=C1)OCC1=CC=CC=C1)C=O)=O.C(C)OC(COC1=C(C=C(C=C1)O)C)=O Chemical compound C(C)OC(COC1=C(C=C(C=C1)OCC1=CC=CC=C1)C=O)=O.C(C)OC(COC1=C(C=C(C=C1)O)C)=O AHNMPDNEZXLGPS-UHFFFAOYSA-N 0.000 description 1
- MJKISFNVASHFOO-UHFFFAOYSA-N C(C)OC(COC1=C(C=C(C=C1)OCC1=CC=CC=C1)C=O)=O.C(C)OC(COC1=C(C=C(C=C1)OCC1=CC=CC=C1)C=O)=O Chemical compound C(C)OC(COC1=C(C=C(C=C1)OCC1=CC=CC=C1)C=O)=O.C(C)OC(COC1=C(C=C(C=C1)OCC1=CC=CC=C1)C=O)=O MJKISFNVASHFOO-UHFFFAOYSA-N 0.000 description 1
- BWEQWVQIVMOUDL-UHFFFAOYSA-N C(C)OC(COC1=C(C=CC=C1)CCC)=O.C(C)OC(COC1=C(C=C(C=C1)S(=O)(=O)Cl)CCC)=O Chemical compound C(C)OC(COC1=C(C=CC=C1)CCC)=O.C(C)OC(COC1=C(C=C(C=C1)S(=O)(=O)Cl)CCC)=O BWEQWVQIVMOUDL-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical compound [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 102220501443 Cytosolic iron-sulfur assembly component 3_C27N_mutation Human genes 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- 101100321992 Drosophila melanogaster ABCD gene Proteins 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 241000282575 Gorilla Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 101001009252 Homo sapiens 2-hydroxyacyl-CoA lyase 1 Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 101150046735 LEPR gene Proteins 0.000 description 1
- 101150063827 LEPROT gene Proteins 0.000 description 1
- 229910010084 LiAlH4 Inorganic materials 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 229910017974 NH40H Inorganic materials 0.000 description 1
- 101100109871 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) aro-8 gene Proteins 0.000 description 1
- 101100281518 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) fox-2 gene Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000282579 Pan Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000005819 Potassium phosphonate Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108091027981 Response element Proteins 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- QIOZLISABUUKJY-UHFFFAOYSA-N Thiobenzamide Chemical compound NC(=S)C1=CC=CC=C1 QIOZLISABUUKJY-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 1
- 238000007239 Wittig reaction Methods 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- JVVXZOOGOGPDRZ-SLFFLAALSA-N [(1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methanamine Chemical compound NC[C@]1(C)CCC[C@]2(C)C3=CC=C(C(C)C)C=C3CC[C@H]21 JVVXZOOGOGPDRZ-SLFFLAALSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012042 active reagent Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001351 alkyl iodides Chemical class 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- 238000010936 aqueous wash Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
- 208000015294 blood coagulation disease Diseases 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 229960004424 carbon dioxide Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 230000004700 cellular uptake Effects 0.000 description 1
- 150000005829 chemical entities Chemical class 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 239000007958 cherry flavor Substances 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000006210 cyclodehydration reaction Methods 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- KQWGXHWJMSMDJJ-UHFFFAOYSA-N cyclohexyl isocyanate Chemical compound O=C=NC1CCCCC1 KQWGXHWJMSMDJJ-UHFFFAOYSA-N 0.000 description 1
- 238000006264 debenzylation reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- FSEUPUDHEBLWJY-HWKANZROSA-N diacetylmonoxime Chemical compound CC(=O)C(\C)=N\O FSEUPUDHEBLWJY-HWKANZROSA-N 0.000 description 1
- 239000012973 diazabicyclooctane Substances 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- 229940042935 dichlorodifluoromethane Drugs 0.000 description 1
- 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- YXXXKCDYKKSZHL-UHFFFAOYSA-M dipotassium;dioxido(oxo)phosphanium Chemical compound [K+].[K+].[O-][P+]([O-])=O YXXXKCDYKKSZHL-UHFFFAOYSA-M 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 229940112141 dry powder inhaler Drugs 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 description 1
- BZYDBVXKSZOWLF-UHFFFAOYSA-N ethyl 2-(2-benzyl-4-hydroxyphenoxy)-2-methylpropanoate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(O)C=C1CC1=CC=CC=C1 BZYDBVXKSZOWLF-UHFFFAOYSA-N 0.000 description 1
- IKHCYBSXTLNZNR-UHFFFAOYSA-N ethyl 2-(2-but-1-enyl-5-phenylmethoxyphenoxy)-2-methylpropanoate Chemical compound C1=C(C=CCC)C(OC(C)(C)C(=O)OCC)=CC(OCC=2C=CC=CC=2)=C1 IKHCYBSXTLNZNR-UHFFFAOYSA-N 0.000 description 1
- ZDXXDGBJBQEADN-UHFFFAOYSA-N ethyl 2-(2-ethenyl-4-phenylmethoxyphenoxy)acetate Chemical compound C1=C(C=C)C(OCC(=O)OCC)=CC=C1OCC1=CC=CC=C1 ZDXXDGBJBQEADN-UHFFFAOYSA-N 0.000 description 1
- VUPMMGFDFRPPDE-UHFFFAOYSA-N ethyl 2-(2-formyl-4-phenylmethoxyphenoxy)-2-methylpropanoate Chemical compound C1=C(C=O)C(OC(C)(C)C(=O)OCC)=CC=C1OCC1=CC=CC=C1 VUPMMGFDFRPPDE-UHFFFAOYSA-N 0.000 description 1
- PBNAWTJZYVLBIP-UHFFFAOYSA-N ethyl 2-(3-hydroxyphenoxy)-2-methylpropanoate Chemical compound CCOC(=O)C(C)(C)OC1=CC=CC(O)=C1 PBNAWTJZYVLBIP-UHFFFAOYSA-N 0.000 description 1
- FNPRJSTVTHTQBZ-UHFFFAOYSA-N ethyl 2-(4-chlorosulfonyl-2-propylphenoxy)acetate Chemical compound CCCC1=CC(S(Cl)(=O)=O)=CC=C1OCC(=O)OCC FNPRJSTVTHTQBZ-UHFFFAOYSA-N 0.000 description 1
- TWOXXZSIIFYOTM-UHFFFAOYSA-N ethyl 2-(4-hydroxy-2,6-dipropylphenoxy)-2-methylpropanoate Chemical compound CCCC1=CC(O)=CC(CCC)=C1OC(C)(C)C(=O)OCC TWOXXZSIIFYOTM-UHFFFAOYSA-N 0.000 description 1
- WBFTYAULZDFKSM-UHFFFAOYSA-N ethyl 2-[2-(cyclohexylmethyl)-4-[2-(2-cyclohexyl-5-methyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=C(CC2CCCCC2)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C1CCCCC1 WBFTYAULZDFKSM-UHFFFAOYSA-N 0.000 description 1
- FIRJGTMIYGSNNM-UHFFFAOYSA-N ethyl 2-[2-(cyclohexylmethyl)-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=C(CC2CCCCC2)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C1=CC=CC=C1 FIRJGTMIYGSNNM-UHFFFAOYSA-N 0.000 description 1
- OGASXCFHSHNMBJ-UHFFFAOYSA-N ethyl 2-[2-(cyclohexylmethyl)-4-[2-(5-methyl-2-thiophen-2-yl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=C(CC2CCCCC2)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C1=CC=CS1 OGASXCFHSHNMBJ-UHFFFAOYSA-N 0.000 description 1
- HEVQFWCOZHLOFH-UHFFFAOYSA-N ethyl 2-[2-(cyclohexylmethyl)-4-[2-[5-methyl-2-(3-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=C(CC2CCCCC2)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C(C=1)=CC=CC=1C1=CC=CC=C1 HEVQFWCOZHLOFH-UHFFFAOYSA-N 0.000 description 1
- ZMRYIADDIWMZGC-UHFFFAOYSA-N ethyl 2-[2-(cyclohexylmethyl)-4-[2-[5-methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=C(CC2CCCCC2)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C(C=C1)=CC=C1C1=CC=CC=C1 ZMRYIADDIWMZGC-UHFFFAOYSA-N 0.000 description 1
- YJOWVBBKYHAVSG-UHFFFAOYSA-N ethyl 2-[2-[hydroxy(phenyl)methyl]-4-phenylmethoxyphenoxy]-2-methylpropanoate Chemical compound C1=C(C(O)C=2C=CC=CC=2)C(OC(C)(C)C(=O)OCC)=CC=C1OCC1=CC=CC=C1 YJOWVBBKYHAVSG-UHFFFAOYSA-N 0.000 description 1
- NILWRVVXJYFBEM-UHFFFAOYSA-N ethyl 2-[2-[hydroxy(phenyl)methyl]-4-phenylmethoxyphenoxy]-2-methylpropanoate;2-[hydroxy(phenyl)methyl]-4-phenylmethoxyphenol Chemical compound C=1C(OCC=2C=CC=CC=2)=CC=C(O)C=1C(O)C1=CC=CC=C1.C1=C(C(O)C=2C=CC=CC=2)C(OC(C)(C)C(=O)OCC)=CC=C1OCC1=CC=CC=C1 NILWRVVXJYFBEM-UHFFFAOYSA-N 0.000 description 1
- GDHKZOPQWDFBGO-UHFFFAOYSA-N ethyl 2-[2-benzyl-4-[2-(2-cyclohexyl-5-methyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=C(CC=2C=CC=CC=2)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C1CCCCC1 GDHKZOPQWDFBGO-UHFFFAOYSA-N 0.000 description 1
- YENJVUJALXGYDP-UHFFFAOYSA-N ethyl 2-[2-benzyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=C(CC=2C=CC=CC=2)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C1=CC=CC=C1 YENJVUJALXGYDP-UHFFFAOYSA-N 0.000 description 1
- MTHJLLNWYYUJRP-UHFFFAOYSA-N ethyl 2-[2-butyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=C(OC(C)(C)C(=O)OCC)C(CCCC)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 MTHJLLNWYYUJRP-UHFFFAOYSA-N 0.000 description 1
- DIWYKGQLXJUEEY-UHFFFAOYSA-N ethyl 2-[2-butyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]acetate Chemical compound C1=C(OCC(=O)OCC)C(CCCC)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 DIWYKGQLXJUEEY-UHFFFAOYSA-N 0.000 description 1
- NHPBDDRJRDZDFK-UHFFFAOYSA-N ethyl 2-[2-ethyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=C(CC)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 NHPBDDRJRDZDFK-UHFFFAOYSA-N 0.000 description 1
- ZUKNQEJOELYWEQ-UHFFFAOYSA-N ethyl 2-[2-ethyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]acetate Chemical compound C1=C(CC)C(OCC(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 ZUKNQEJOELYWEQ-UHFFFAOYSA-N 0.000 description 1
- YMLBOFCCHXTIEL-UHFFFAOYSA-N ethyl 2-[3-(cyclohexylmethyl)-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1CCCCC1CC1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C1=CC=CC=C1 YMLBOFCCHXTIEL-UHFFFAOYSA-N 0.000 description 1
- MHIPEWOTOPGBOS-UHFFFAOYSA-N ethyl 2-[3-butyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]acetate Chemical compound CCCCC1=CC(OCC(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 MHIPEWOTOPGBOS-UHFFFAOYSA-N 0.000 description 1
- HPIGEDGPGKCNHM-UHFFFAOYSA-N ethyl 2-[3-ethyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoate Chemical compound CCC1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 HPIGEDGPGKCNHM-UHFFFAOYSA-N 0.000 description 1
- GDHJOVRDAOSSES-UHFFFAOYSA-N ethyl 2-[4-[2-(2-cyclohexyl-5-methyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C2CCCCC2)=N1 GDHJOVRDAOSSES-UHFFFAOYSA-N 0.000 description 1
- UKHLMNUDSTWGGJ-UHFFFAOYSA-N ethyl 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2,6-dipropylphenoxy]acetate Chemical compound CCCC1=C(OCC(=O)OCC)C(CCC)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 UKHLMNUDSTWGGJ-UHFFFAOYSA-N 0.000 description 1
- ZZARLOGTXPRLND-UHFFFAOYSA-N ethyl 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-(5-phenylpentyl)phenoxy]acetate Chemical compound C1=C(CCCCCC=2C=CC=CC=2)C(OCC(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C1=CC=CC=C1 ZZARLOGTXPRLND-UHFFFAOYSA-N 0.000 description 1
- SEAPYCDOHKYQGE-UHFFFAOYSA-N ethyl 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-propylphenoxy]acetate Chemical compound C1=C(OCC(=O)OCC)C(CCC)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 SEAPYCDOHKYQGE-UHFFFAOYSA-N 0.000 description 1
- XJPIYHFJZJOTPX-UHFFFAOYSA-N ethyl 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3-(2-methylpropyl)phenoxy]acetate Chemical compound CC(C)CC1=CC(OCC(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 XJPIYHFJZJOTPX-UHFFFAOYSA-N 0.000 description 1
- FEMPTJVHFRVENJ-UHFFFAOYSA-N ethyl 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3-(5-phenylpentyl)phenoxy]acetate Chemical compound C=1C=CC=CC=1CCCCCC1=CC(OCC(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C1=CC=CC=C1 FEMPTJVHFRVENJ-UHFFFAOYSA-N 0.000 description 1
- DOFLTLIYBCYNRZ-UHFFFAOYSA-N ethyl 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-3-phenylpropanoate Chemical compound C=1C=C(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)C=CC=1OC(C(=O)OCC)CC1=CC=CC=C1 DOFLTLIYBCYNRZ-UHFFFAOYSA-N 0.000 description 1
- CVPJINVOQIVHAP-UHFFFAOYSA-N ethyl 2-[4-[2-[2-(3,5-ditert-butyl-4-hydroxyphenyl)-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=COC(C=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=N1 CVPJINVOQIVHAP-UHFFFAOYSA-N 0.000 description 1
- MFLUADOEXYJEBW-UHFFFAOYSA-N ethyl 2-[4-[2-[2-(3-ethenylphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=C(C=C)C=CC=2)=N1 MFLUADOEXYJEBW-UHFFFAOYSA-N 0.000 description 1
- WNYIXXVJDBFTMQ-UHFFFAOYSA-N ethyl 2-[4-[2-[2-(3-ethylphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=C(CC)C=CC=2)=N1 WNYIXXVJDBFTMQ-UHFFFAOYSA-N 0.000 description 1
- IWPWIYMVQMPRBT-UHFFFAOYSA-N ethyl 2-[4-[2-[2-(3-ethylphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate;2-[4-[2-[2-(3-ethylphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoic acid Chemical compound CCC1=CC=CC(C=2OC(C)=C(CCOC=3C=CC(OC(C)(C)C(O)=O)=CC=3)N=2)=C1.C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=C(CC)C=CC=2)=N1 IWPWIYMVQMPRBT-UHFFFAOYSA-N 0.000 description 1
- WUNADIXGQXAHTF-UHFFFAOYSA-N ethyl 2-[4-[2-[2-(4-ethylphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC(CC)=CC=2)=N1 WUNADIXGQXAHTF-UHFFFAOYSA-N 0.000 description 1
- JXLWMMMLQIKTIX-UHFFFAOYSA-N ethyl 2-[4-[2-[2-(4-ethynylphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenoxy]-2-methylpropanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC(=CC=2)C#C)=N1 JXLWMMMLQIKTIX-UHFFFAOYSA-N 0.000 description 1
- GEAYRWPGAMGEEI-UHFFFAOYSA-N ethyl 2-[5-[2-(2-cyclohexyl-5-methyl-1,3-oxazol-4-yl)ethoxy]-2-propylphenoxy]-2-methylpropanoate Chemical compound C1=C(OC(C)(C)C(=O)OCC)C(CCC)=CC=C1OCCC1=C(C)OC(C2CCCCC2)=N1 GEAYRWPGAMGEEI-UHFFFAOYSA-N 0.000 description 1
- FIHGITXPNXOCKG-UHFFFAOYSA-N ethyl 2-methyl-2-[2-[(3-methylphenoxy)methyl]-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]propanoate Chemical compound C1=C(COC=2C=C(C)C=CC=2)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C1=CC=CC=C1 FIHGITXPNXOCKG-UHFFFAOYSA-N 0.000 description 1
- HRXGXOPGIFNYHW-UHFFFAOYSA-N ethyl 2-methyl-2-[2-methyl-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]propanoate Chemical compound C1=C(C)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 HRXGXOPGIFNYHW-UHFFFAOYSA-N 0.000 description 1
- XKBAVBMXYJORGR-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2,6-dipropylphenoxy]propanoate Chemical compound CCCC1=C(OC(C)(C)C(=O)OCC)C(CCC)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 XKBAVBMXYJORGR-UHFFFAOYSA-N 0.000 description 1
- WYSRZLOXQVARAC-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-(2-methylpropyl)phenoxy]propanoate Chemical compound C1=C(CC(C)C)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 WYSRZLOXQVARAC-UHFFFAOYSA-N 0.000 description 1
- MWQAMQGLXVWZKD-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-(2-phenylethyl)phenoxy]propanoate Chemical compound C1=C(CCC=2C=CC=CC=2)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C1=CC=CC=C1 MWQAMQGLXVWZKD-UHFFFAOYSA-N 0.000 description 1
- QMPTUUPDSZRLSR-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-(5-phenylpentyl)phenoxy]propanoate Chemical compound C1=C(CCCCCC=2C=CC=CC=2)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C1=CC=CC=C1 QMPTUUPDSZRLSR-UHFFFAOYSA-N 0.000 description 1
- PVLJGVUIYXJHTR-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-propylphenoxy]propanoate Chemical compound C1=C(OC(C)(C)C(=O)OCC)C(CCC)=CC(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)=C1 PVLJGVUIYXJHTR-UHFFFAOYSA-N 0.000 description 1
- ZBIFGPQLHBNFPP-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3-(2-methylpropyl)phenoxy]propanoate Chemical compound CC(C)CC1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 ZBIFGPQLHBNFPP-UHFFFAOYSA-N 0.000 description 1
- XJTJHWVZUQWADU-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3-(2-phenylethyl)phenoxy]propanoate Chemical compound C=1C=CC=CC=1CCC1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C1=CC=CC=C1 XJTJHWVZUQWADU-UHFFFAOYSA-N 0.000 description 1
- GDKKJWAOYLPNTP-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3-(5-phenylpentyl)phenoxy]propanoate Chemical compound C=1C=CC=CC=1CCCCCC1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C1=CC=CC=C1 GDKKJWAOYLPNTP-UHFFFAOYSA-N 0.000 description 1
- PGAUFKQNECJTEI-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]-3-phenylpropanoate Chemical compound C=1C=C(OCCC2=C(OC(=N2)C=2C=CC=CC=2)C)C=CC=1OC(C)(C(=O)OCC)CC1=CC=CC=C1 PGAUFKQNECJTEI-UHFFFAOYSA-N 0.000 description 1
- QABJMQRLYPODKR-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethylsulfanyl]phenoxy]propanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1SCCC1=C(C)OC(C=2C=CC=CC=2)=N1 QABJMQRLYPODKR-UHFFFAOYSA-N 0.000 description 1
- RAIYJOPRKSBTPD-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-(5-methyl-2-phenyl-1,3-thiazol-4-yl)ethoxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)SC(C=2C=CC=CC=2)=N1 RAIYJOPRKSBTPD-UHFFFAOYSA-N 0.000 description 1
- WUTAEXCGXXFZJJ-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-[5-methyl-2-(3-phenoxyphenyl)-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=C(OC=3C=CC=CC=3)C=CC=2)=N1 WUTAEXCGXXFZJJ-UHFFFAOYSA-N 0.000 description 1
- QPBDRYSIVUCUQB-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-[5-methyl-2-(3-phenoxyphenyl)-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoate;2-methyl-2-[4-[2-[5-methyl-2-(3-phenoxyphenyl)-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoic acid Chemical compound CC=1OC(C=2C=C(OC=3C=CC=CC=3)C=CC=2)=NC=1CCOC1=CC=C(OC(C)(C)C(O)=O)C=C1.C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=C(OC=3C=CC=CC=3)C=CC=2)=N1 QPBDRYSIVUCUQB-UHFFFAOYSA-N 0.000 description 1
- YHTQRMGBCKBEDE-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-[5-methyl-2-(3-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-(2-phenylethyl)phenoxy]propanoate Chemical compound C1=C(CCC=2C=CC=CC=2)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C(C=1)=CC=CC=1C1=CC=CC=C1 YHTQRMGBCKBEDE-UHFFFAOYSA-N 0.000 description 1
- VGQXIFTUBDCPBC-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-[5-methyl-2-(4-phenoxyphenyl)-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC(OC=3C=CC=CC=3)=CC=2)=N1 VGQXIFTUBDCPBC-UHFFFAOYSA-N 0.000 description 1
- CUMWCVCCXPOHQM-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-[5-methyl-2-(4-phenylmethoxyphenyl)-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)=N1 CUMWCVCCXPOHQM-UHFFFAOYSA-N 0.000 description 1
- WJNVMJNLMSFPDG-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-[5-methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-(2-phenylethyl)phenoxy]propanoate Chemical compound C1=C(CCC=2C=CC=CC=2)C(OC(C)(C)C(=O)OCC)=CC=C1OCCC(=C(O1)C)N=C1C(C=C1)=CC=C1C1=CC=CC=C1 WJNVMJNLMSFPDG-UHFFFAOYSA-N 0.000 description 1
- IPKUTGYQZWLTKC-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-[5-methyl-2-[3-(2-phenylethyl)phenyl]-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=C(CCC=3C=CC=CC=3)C=CC=2)=N1 IPKUTGYQZWLTKC-UHFFFAOYSA-N 0.000 description 1
- GJWWXPHVGYVPKK-UHFFFAOYSA-N ethyl 2-methyl-2-[4-[2-[5-methyl-2-[4-(2-phenylethyl)phenyl]-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)(C)C(=O)OCC)=CC=C1OCCC1=C(C)OC(C=2C=CC(CCC=3C=CC=CC=3)=CC=2)=N1 GJWWXPHVGYVPKK-UHFFFAOYSA-N 0.000 description 1
- OWQRISHBALQUOO-UHFFFAOYSA-N ethyl 2-methyl-2-[5-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-propylphenoxy]propanoate Chemical compound C1=C(OC(C)(C)C(=O)OCC)C(CCC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 OWQRISHBALQUOO-UHFFFAOYSA-N 0.000 description 1
- XCPXPFNKTCFWTA-UHFFFAOYSA-N ethyl carbonobromidate Chemical compound CCOC(Br)=O XCPXPFNKTCFWTA-UHFFFAOYSA-N 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- CNUDBTRUORMMPA-UHFFFAOYSA-N formylthiophene Chemical compound O=CC1=CC=CS1 CNUDBTRUORMMPA-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000009229 glucose formation Effects 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 230000004190 glucose uptake Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- FMKOJHQHASLBPH-UHFFFAOYSA-N isopropyl iodide Chemical compound CC(C)I FMKOJHQHASLBPH-UHFFFAOYSA-N 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical class CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- IZDROVVXIHRYMH-UHFFFAOYSA-N methanesulfonic anhydride Chemical compound CS(=O)(=O)OS(C)(=O)=O IZDROVVXIHRYMH-UHFFFAOYSA-N 0.000 description 1
- IGRGQWSVDTYHID-UHFFFAOYSA-N methyl 2-(5-methyl-2-phenyl-1,3-thiazol-4-yl)acetate Chemical compound S1C(C)=C(CC(=O)OC)N=C1C1=CC=CC=C1 IGRGQWSVDTYHID-UHFFFAOYSA-N 0.000 description 1
- CWNCXWPUUKALOT-UHFFFAOYSA-N methyl 2-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)C(=O)OC)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 CWNCXWPUUKALOT-UHFFFAOYSA-N 0.000 description 1
- HCBQTGAZENNMLM-UHFFFAOYSA-N methyl 4-bromo-3-oxopentanoate Chemical compound COC(=O)CC(=O)C(C)Br HCBQTGAZENNMLM-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- LSEFCHWGJNHZNT-UHFFFAOYSA-M methyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 LSEFCHWGJNHZNT-UHFFFAOYSA-M 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 125000006203 morpholinoethyl group Chemical group [H]C([H])(*)C([H])([H])N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- PHWISQNXPLXQRU-UHFFFAOYSA-N n,n-dimethylcarbamothioyl chloride Chemical compound CN(C)C(Cl)=S PHWISQNXPLXQRU-UHFFFAOYSA-N 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003791 organic solvent mixture Substances 0.000 description 1
- LMYJGUNNJIDROI-UHFFFAOYSA-N oxan-4-ol Chemical compound OC1CCOCC1 LMYJGUNNJIDROI-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 1
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- 125000004346 phenylpentyl group Chemical group C1(=CC=CC=C1)CCCCC* 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 239000013062 quality control Sample Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 239000002287 radioligand Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000012439 solid excipient Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000003797 solvolysis reaction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003461 sulfonyl halides Chemical class 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- QIWRFOJWQSSRJZ-UHFFFAOYSA-N tributyl(ethenyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C=C QIWRFOJWQSSRJZ-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 229940029284 trichlorofluoromethane Drugs 0.000 description 1
- GGUBFICZYGKNTD-UHFFFAOYSA-N triethyl phosphonoacetate Chemical compound CCOC(=O)CP(=O)(OCC)OCC GGUBFICZYGKNTD-UHFFFAOYSA-N 0.000 description 1
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
- XMQSELBBYSAURN-UHFFFAOYSA-M triphenyl(propyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CCC)C1=CC=CC=C1 XMQSELBBYSAURN-UHFFFAOYSA-M 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
- GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 description 1
- 229960001641 troglitazone Drugs 0.000 description 1
- GXPHKUHSUJUWKP-NTKDMRAZSA-N troglitazone Natural products C([C@@]1(OC=2C(C)=C(C(=C(C)C=2CC1)O)C)C)OC(C=C1)=CC=C1C[C@H]1SC(=O)NC1=O GXPHKUHSUJUWKP-NTKDMRAZSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229930195724 β-lactose Natural products 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22723300P | 2000-08-23 | 2000-08-23 | |
| US60/227,233 | 2000-08-23 | ||
| PCT/US2001/022615 WO2002018355A1 (en) | 2000-08-23 | 2001-08-23 | Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2420178A1 true CA2420178A1 (en) | 2002-03-07 |
Family
ID=22852305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002420178A Abandoned CA2420178A1 (en) | 2000-08-23 | 2001-08-23 | Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US6982278B2 (enExample) |
| EP (1) | EP1313715B1 (enExample) |
| JP (1) | JP2004509084A (enExample) |
| AT (1) | ATE368653T1 (enExample) |
| AU (1) | AU2001284658A1 (enExample) |
| CA (1) | CA2420178A1 (enExample) |
| DE (1) | DE60129712T2 (enExample) |
| ES (1) | ES2288982T3 (enExample) |
| WO (1) | WO2002018355A1 (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7041691B1 (en) | 1999-06-30 | 2006-05-09 | Amgen Inc. | Compounds for the modulation of PPARγ activity |
| US20030171399A1 (en) | 2000-06-28 | 2003-09-11 | Tularik Inc. | Quinolinyl and benzothiazolyl modulators |
| MXPA03001558A (es) | 2000-08-23 | 2003-06-06 | Lilly Co Eli | Agonistas del receptor activado del proliferador de peroxisoma. |
| CA2420178A1 (en) * | 2000-08-23 | 2002-03-07 | Eli Lilly And Company | Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |
| US7176224B2 (en) | 2000-08-23 | 2007-02-13 | Eli Lilly And Company | Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists |
| US7105551B2 (en) | 2000-12-20 | 2006-09-12 | Smithkline Beecham Corporation | Thiazole derivatives for treating PPAR related disorders |
| IL159002A0 (en) * | 2001-06-07 | 2004-05-12 | Lilly Co Eli | Modulators of peroxisome proliferator activated receptors (ppar) |
| US20110065129A1 (en) | 2001-07-27 | 2011-03-17 | Lowe Derek B | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| AR036237A1 (es) * | 2001-07-27 | 2004-08-25 | Bayer Corp | Derivados del acido indan acetico, intermediarios, y metodo para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento |
| ITRM20020014A1 (it) * | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
| JP2005529077A (ja) | 2002-02-25 | 2005-09-29 | イーライ・リリー・アンド・カンパニー | ペルオキシソーム増殖因子活性化受容体調節物質 |
| WO2003072102A1 (en) | 2002-02-25 | 2003-09-04 | Eli Lilly And Company | Peroxisome proliferator activated receptor modulators |
| US6833380B2 (en) | 2002-03-07 | 2004-12-21 | Warner-Lambert Company, Llc | Compounds that modulate PPAR activity and methods of preparation |
| US6867224B2 (en) | 2002-03-07 | 2005-03-15 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods of preparation |
| UA79755C2 (en) * | 2002-04-16 | 2007-07-25 | Bayer Pharmaceuticals Corp | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| WO2004011446A1 (en) * | 2002-07-26 | 2004-02-05 | Bayer Pharmaceuticals Corporation | Indane, dihydrobenzofuran, and tetrahydronaphthalene carboxylic acid derivatives and their use as antidiabetics |
| US7129268B2 (en) * | 2002-10-28 | 2006-10-31 | Novo Nordisk A/S | Peroxisome proliferator activated receptor-active arylene acetic acid derivatives |
| CA2503117C (en) * | 2002-11-08 | 2010-12-21 | F. Hoffmann-La Roche Ag | Substituted 4-alkoxyoxazol derivatives as ppar agonists |
| US7192970B2 (en) * | 2002-11-26 | 2007-03-20 | Chipscreen Biosciences, Ltd. | Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity |
| BRPI0407180A (pt) | 2003-02-14 | 2006-02-07 | Lilly Co Eli | Composto, composição farmacêutica, métodos para modular um receptor ativado pelo proliferador de peroxissoma, para tratar ou prevenir uma doença ou condição, para diminuir a glicose no sangue em um mamìfero, para tratar ou prevenir diabetes mellitus, doença cardiovascular e sìndrome x em um mamìfero, e, uso de um composto |
| DE10308355A1 (de) | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
| DE10308351A1 (de) | 2003-02-27 | 2004-11-25 | Aventis Pharma Deutschland Gmbh | 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US7244763B2 (en) | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
| EP1658273B1 (en) | 2003-08-20 | 2007-01-03 | Eli Lilly And Company | Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| MXPA06001916A (es) * | 2003-08-20 | 2006-05-17 | Lilly Co Eli | Compuestos, metodos y formulaciones para el suministro oral de un compuesto peptidico similar a glucagona (glp)-i o un peptido agonista del receptor de melanocortina 4 (mc4). |
| US7223761B2 (en) | 2003-10-03 | 2007-05-29 | Amgen Inc. | Salts and polymorphs of a potent antidiabetic compound |
| KR100849352B1 (ko) * | 2003-11-05 | 2008-07-29 | 에프. 호프만-라 로슈 아게 | Ppar 활성화제로서 벤조-융합된 화합물 |
| EP1682508A1 (en) * | 2003-11-05 | 2006-07-26 | F. Hoffmann-La Roche Ag | Phenyl derivatives as ppar agonists |
| EP1745014B1 (en) * | 2004-05-05 | 2011-07-06 | High Point Pharmaceuticals, LLC | Novel compounds, their preparation and use |
| JP2007536341A (ja) * | 2004-05-05 | 2007-12-13 | ノボ ノルディスク アクティーゼルスカブ | Pparアゴニストとしてのフェノキシ酢酸誘導体 |
| JP2007284352A (ja) * | 2004-08-05 | 2007-11-01 | Dai Ichi Seiyaku Co Ltd | ピラゾール誘導体 |
| WO2006108491A1 (en) * | 2005-04-11 | 2006-10-19 | Dsm Fine Chemicals Austria Nfg Gmbh & Co Kg | Improved process for preparing oxazole nitriles |
| US7943613B2 (en) | 2005-12-22 | 2011-05-17 | High Point Pharmaceuticals, Llc | Compounds, their preparation and use |
| JO3598B1 (ar) | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني |
| CA2721060A1 (en) * | 2008-04-09 | 2009-10-15 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
| US8541581B2 (en) | 2009-04-07 | 2013-09-24 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
| US8546564B2 (en) | 2009-04-07 | 2013-10-01 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
| JP2013518886A (ja) * | 2010-02-03 | 2013-05-23 | インフイニトイ プハルマセウトイカルス インコーポレイテッド | 脂肪酸アミドヒドロラーゼ阻害剤 |
| US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| CN104230836B (zh) * | 2014-09-29 | 2016-08-31 | 中国科学院成都生物研究所 | 苯基噁唑类化合物及在制备治疗癌症的药中的应用 |
| US11078528B2 (en) | 2015-10-12 | 2021-08-03 | Advanced Cell Diagnostics, Inc. | In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto |
| BR112023001048A2 (pt) | 2020-07-22 | 2023-04-04 | Reneo Pharmaceuticals Inc | Agonista de ppar-delta cristalino |
| WO2023147309A1 (en) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Use of ppar-delta agonists in the treatment of disease |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5089514A (en) * | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| US5232945A (en) * | 1992-07-20 | 1993-08-03 | Pfizer Inc. | 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives |
| US5902726A (en) * | 1994-12-23 | 1999-05-11 | Glaxo Wellcome Inc. | Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma |
| JPH08325250A (ja) * | 1995-05-31 | 1996-12-10 | Sumitomo Metal Ind Ltd | 新規置換フェノール誘導体 |
| WO1997028115A1 (en) | 1996-02-02 | 1997-08-07 | Merck & Co., Inc. | Antidiabetic agents |
| GB9604242D0 (en) * | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| CZ53699A3 (cs) | 1996-08-19 | 1999-07-14 | Japan Tobacco Inc. | Deriváty propionové kyseliny a jejich použití |
| KR100620337B1 (ko) | 1998-03-10 | 2006-09-13 | 오노 야꾸힝 고교 가부시키가이샤 | 카르복실산 유도체와 그 유도체를 유효 성분으로서함유하는 약제 |
| US6121300A (en) * | 1998-11-10 | 2000-09-19 | Wagle; Dilip R. | Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
| AU7073400A (en) * | 1999-08-27 | 2001-03-26 | Eli Lilly And Company | Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| JP4316787B2 (ja) * | 2000-01-11 | 2009-08-19 | 壽製薬株式会社 | エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、 |
| MXPA03001558A (es) * | 2000-08-23 | 2003-06-06 | Lilly Co Eli | Agonistas del receptor activado del proliferador de peroxisoma. |
| US7176224B2 (en) * | 2000-08-23 | 2007-02-13 | Eli Lilly And Company | Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists |
| CA2420178A1 (en) * | 2000-08-23 | 2002-03-07 | Eli Lilly And Company | Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |
-
2001
- 2001-08-23 CA CA002420178A patent/CA2420178A1/en not_active Abandoned
- 2001-08-23 US US10/343,474 patent/US6982278B2/en not_active Expired - Fee Related
- 2001-08-23 AU AU2001284658A patent/AU2001284658A1/en not_active Abandoned
- 2001-08-23 DE DE60129712T patent/DE60129712T2/de not_active Expired - Lifetime
- 2001-08-23 EP EP01963732A patent/EP1313715B1/en not_active Expired - Lifetime
- 2001-08-23 ES ES01963732T patent/ES2288982T3/es not_active Expired - Lifetime
- 2001-08-23 AT AT01963732T patent/ATE368653T1/de not_active IP Right Cessation
- 2001-08-23 JP JP2002523473A patent/JP2004509084A/ja not_active Revoked
- 2001-08-23 WO PCT/US2001/022615 patent/WO2002018355A1/en not_active Ceased
-
2005
- 2005-07-14 US US11/181,640 patent/US7351728B2/en not_active Expired - Fee Related
-
2008
- 2008-01-11 US US11/972,668 patent/US20080146631A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004509084A (ja) | 2004-03-25 |
| US20040024034A1 (en) | 2004-02-05 |
| DE60129712D1 (de) | 2007-09-13 |
| US6982278B2 (en) | 2006-01-03 |
| EP1313715B1 (en) | 2007-08-01 |
| US20050250825A1 (en) | 2005-11-10 |
| AU2001284658A1 (en) | 2002-03-13 |
| US7351728B2 (en) | 2008-04-01 |
| DE60129712T2 (de) | 2008-07-03 |
| ES2288982T3 (es) | 2008-02-01 |
| EP1313715A1 (en) | 2003-05-28 |
| ATE368653T1 (de) | 2007-08-15 |
| WO2002018355A1 (en) | 2002-03-07 |
| US20080146631A1 (en) | 2008-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1313715B1 (en) | Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists | |
| US6417212B1 (en) | Modulators of peroxisome proliferator activated receptors | |
| EP1313716B1 (en) | Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists | |
| EP1480640A1 (en) | Peroxisome proliferator activated receptor modulators | |
| JP2007502815A (ja) | Ppar調節因子 | |
| EP1313717B1 (en) | Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |